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Abstract 
Peptides are materials that, as a result of their polymeric nature, possess enormous 
versatility and customizability. Multidomain peptides are a class of peptides that self-
assemble to form stable, cytocompatible hydro gels. They have an ABA block motif, in 
which the A block is composed of charged amino acids, such as lysine, and the B block 
consists of alternating hydrophilic and hydrophobic amino acids, such as glutamine and 
leucine. The B block forms a facial amphiphile that drives self-assembly. The charged A 
blocks simultaneously limit self-assembly and improve solubility. Self-assembly is 
triggered by charge screening of these charged amino acids, enabling the formation of ~­
sheet fibers. The development of an extended nanofiber network can result in the 
formation of a hydrogel. 
Systematic modifications to both the A and B blocks were investigated, and it was 
found that sequence modifications have a large impact on peptide nanostructure and 
hydrogel rheology. The first modification examined is the substitution of amino acids 
within the hydrophilic positions of the B block. The second set of modifications 
investigated was the incorporation of aromatic amino acids in the B block. Finally, the 
charged block was varied to generate different net charges on the peptides, a change 
which impacted the ability to use these peptides in cell culture. 
Two applications of multi domain peptide nanofibers are explored, the first of 
which is the delivery of novel therapies in vivo. One multidomain peptide is able to form 
hydrogels that undergo shear-thinning and rapid recovery. This gel can be loaded with 
cytokines and growth factors that have been secreted by embryonic stem cells, and these 
molecules can be subsequently released in a therapeutic setting. Another application for 
multidomain peptide is their use as biocompatible surfactants. Single-walled carbon 
nanotubes have been widely investigated for their unique optical and electrical properties, 
but their solubility in aqueous systems has been a challenge. Multidomain peptides 
solubilize carbon nanotubes, are less cytotoxic than detergents such as SDBS, and 
preserve the ability of carbon nanotubes to fluoresce. Some of these peptides are also 
compatible with cell culture, allowing the delivery of single-walled carbon nanotubes to 
cells. 
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Chapter 1: Introduction 
A. Supramolecular Chemistry: Thinking Beyond the Molecule 
One of the most rapidly evolving and intriguing areas of chemistry today is the field 
of supramolecular chemistry. Inspired by the complex yet highly functional structures 
found naturally in biology, supramolecular chemistry builds on traditional synthetic 
chemistry in that it can orchestrate individual molecules into large, organized structures 
via the process of self-assembly. Self-assembly relies on numerous non-covalent 
interactions originating from the chemistry of the constituent molecules and takes place 
in the absence of external forces. Because the chemistry of the component molecules 
alone drives self-assembly, self-assembly processes are subject to equilibrium and thus 
the reactions taking place are often reversible. This offers a useful feature to self-
assembling systems: the possibility of error correction. If one subunit of a larger structure 
is incorporated in an incorrect or energetically unfavorable manner, this subunit may be 
replaced in favor of lower energy interactions. In contrast, in a system that forms covalent 
bonds, the activation energy to correct errors is prohibitively high. This trial-and-error 
process for supramolecular assemblies allows the construction of extremely complicated 
structures. This also allows the accurate construction of hierarchical self-assembled 
materials from the "bottom up." In fact, this "bottom up" approach is at work in most 
systems found in nature. This brief survey of self-assembling systems will examine some 
of these systems found in nature, such as DNA and amyloid-j3 structures. It will then 
illustrate how we might take advantage of the principles employed in these natural 
systems to synthesize increasingly complex nanostructures. 
A variety of synthetic systems have been constructed using the principles of self-
assembly. One well-known type of supramolecular system is the host-guest system l . 
Simple host-guest complexes range from podands and corands and their ligands to the 
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more complex spherands and calixarenes (Figure 1.1). These systems utilize noncovalent 
interactions to keep the guest molecule in place. Other host-guest complexes, such as 
carcerands, l sterically block the movement of the guest atom or molecule. 
Figure 1.1. X-ray crystal structure of a typical calixarene, p-tert-butylcalix[ 4]arene-
toluene. Adapted from Figure 1.23 in reference 1. The host-guest relationship is easily 
observed between the two molecules. 
In addition to host-guest chemistry, other self-assembling molecules have been 
investigated, including porphyrins,2 block copolymers,3 quantum dots,4 and metallic 
nanorods. 5 Vast arrays of even larger nanostructures have been prepared. These range 
from nanotubes6, 7 to nanoribbons8 and nanofibers.9 Synthetic techniques have even 
allowed us to construct molecules that mimic biological systems. An array of bio-inspired 
and biomimetic materials will be discussed here, including collagen-mimetic peptides, 
alpha helical peptide materials, and beta sheet peptide hydro gels. Chapter 2 details the 
initial synthesis and characterization of a class of peptides called multidomain peptides, 
which form beta sheet nanofibers in aqueous solution. Chapter 3 explores the covalent 
modification of these peptides through the use of enzymes. Two chapters are devoted to 
the biological applications of this robust self-assembling system: Chapter 4 shows that 
multi domain peptides can act as surfactants for carbon nanotubes, allowing carbon 
nanotube to be safely delivered in a biological setting. Chapter 5 investigates the use of 
multi domain peptide hydro gels as drug delivery agents both in a cell culture setting as 
well as in laboratory animals. 
B. Self-Assembly of Biological Molecules 
3 
Nearly every type of biological molecule utilizes supramolecular chemistry to 
construct functional structures. Nucleic acid chemistry is one example of such self-
assembly at work. Individual strands of DNA interact with each other via hydrogen bonds 
and n:-stacking interactions to form a double helix. Double helices can then fold, in the 
presence of histones, 10 into organized chromatin structures,11 and they also interact with 
enzymes in predictable ways. 12 Nature has even taken advantage of error correction in 
DNA, a feature that is facilitated by DNA polymerase enzymes. RNA also possesses the 
ability to self-assemble into molecules called ribozymes,13 which are capable of 
catalyzing chemical reactions. Lipids can self-assemble into highly functional structures 
as well, the most well-known of which is the lipid bilayer found in every cell. Outside the 
body, lipids and their derivatives can also assemble into other structures such as 
monolayers14 and liposomes. 15 But supramolecular chemistry is not limited to just lipids 
and nucleic acids. Perhaps there is no better showcase of self-assembly than the vast 
array of functional molecules made from peptides and proteins. 
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Peptides and proteins are linear polymers constructed from amino acids. The wide 
variety of amino acids available, both natural and synthetic, provide a nearly infinite 
number of sequence possibilities. Individual amino acid residues can have drastic effects 
on the peptide secondary structure, leading in tum to a variety of higher order structures. 
The interactions taking place between amino acids when these structures are formed may 
be between peptide backbone atoms or between side chains, between amino acids that are 
close in sequence or very distant, or even between amino acids in different proteins. Once 
the secondary and tertiary structures of individual proteins are established, distinct 
peptides and proteins can self-assemble into functional units. Virus capsids are one such 
unit, whose function is to encase and protect the viral genetic material. The human 
immunodeficiency virus (HIV) capsid is composed of2,000 copies of the protein p24, 
self-assembled into a cone. Adenoviruses, a family of respiratory viruses, have an 
icosahedral capsid composed of 20 identical triangular faces, each consisting of dozens of 
protein molecules. 16,17 Two representations of this viral capsid are shown in Figure 1.2. 
Enzymes are another functional unit made from peptide and/or protein building blocks. 
That these molecules can catalyze nearly any chemical transformation required for life is 
a testament to the incredible flexibility of self-assembly. 
(a) 
~===::::ll IV (Fibre) 
~ III (Penton base) 
~ II{Hexon) 
Y ilia 
• IX 
.. VI 
• VIII 
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Figure 1.2. a) Diagram of the assembled adenovirus icosahedral capsid. b) Three-
dimensional representation of the viral particle, showing the positions of each of the 
capsid proteins. The hexon, penton base and fibre proteins are shown in dark blue, light 
blue and green, respectively. The two minor capsid proteins are superimposed. Protein IX 
is shown in yellow, and protein lIla is shown in red. Adapted from reference 17. 
C. Peptide Self-Assembly 
In recent years, chemists have begun to harness the potential for novel self-assembly 
that peptides and proteins have to offer. Amino acid side chains drive much of the 
chemistry of peptides and proteins. These side chains vary widely in functionality: they 
may be charged, hydrophobic, hydrophilic, aromatic, or a combination of these attributes. 
Charged amino acids can participate in ion-ion or ion-dipole interaction as well as 
hydrogen bonding. Hydrophobic amino acids have the capability of aggregating in order 
to reduce the hydrophobic surface area in contact with water. This creates a hydrophobic 
domain that can be a driving factor in peptide self-assembly. Hydrophilic amino acids 
may interact with water and may also participate in hydrogen bonding. Finally, aromatic 
amino acids have the capability to participate in Jt-Jt stacking with one another. Jt-Jt 
stacking can be a powerful force for self-assembly and contributes to the assembly of 
such systems as amyloid-~ and the DNA double helix. All of these interactions play a 
6 
role in native protein folding, and most are utilized in complex synthetic self-assembled 
systems. Managing these interactions allows a level of control over peptide secondary 
structure. Given the variety of functionalities available in amino acid side chains, it is not 
surprising that we can selectively take advantage of specific interactions between amino 
acid side chains to create a vast array of nanostructures. A variety of synthetic peptides 
have been prepared, leading to nanostructures such as peptide nanotubes,6 collagen-like 
triple helices,18, 19 alpha-helical coiled coils,2° and beta-sheet nanofibers,z1 
1. Cyclic Peptide Nanotubes 
Peptide nanotubes can be constructed from the packing of cyclic peptides, small 
peptides with alternating D- and L-amino acids. This unique type of peptide architecture 
was inspired by the antibiotic gramicidin A.22, 23 The alternating D- and L-residues allow 
all of the side chains to face away from the center of the tube when the molecule is 
cyclized. Homochiral peptides (all D- or all L-amino acids) do not cyclize due to 
unfavorable steric interactions between the amino acids that would reside on the interior 
of the ring. The heterochiral cyclic peptides stack on top of one another to form a hollow 
tube, driven by the formation of anti-parallel hydrogen bonds between adjacent peptides 
(Figure 1.3).6 Extensive stacking leads to the formation ofnanotubular structures. Later 
work by the Ghadiri group showed that the pore size of these tubular structures could be 
varied.24 These nanotubes can function as ion channels when inserted into lipid bilayer 
membranes,zs Outside of a biological environment, multiple peptide nanotubes can also 
interact with one another, forming organized microcrystals in another tier of self-
assembly. These types of peptides and their supramolecular structures have been shown 
to have promising antimicrobial activity.26-28 
Figure 1.3. Peptides have the capability to self-assemble to form hollow nanotubes held 
together by hydrogen bonds. Adapted from reference 6. 
2. Triple Helices: Collagen and Related Structures 
Collagen is an excellent example of a peptide with hierarchical self-assembly. 
Collagen is the most abundant protein found in the body and a major component of the 
extracellular matrix. Its secondary structure is a signature polypeptide triple helix, 
characterized by the repeating sequence X-Y-Gly. Ramachandran was the first to 
postulate the triple helical structure,29, 30 a model that was revised by Rich and Crick31 
and later validated by the Brodsky group.32 In this model, the X position is commonly 
occupied by proline and the Y position is most frequently occupied by hydroxyproline 
(abbreviated 0), a post-translationally modified amino acid derived from proline. 
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Hydroxyproline provides a stabilizing effect to the triple helix over proline alone. The 
mechanism of this stabilization has been widely investigated. Based on work by the 
Brodsky group, it has been suggested that hydroxyproline participates in extensive 
hydrogen bonding with water, which stabilizes the helix.32 The Raines group has 
suggested that this stabilization arises from stereoelectronic effects: the addition of a 
hydroxyl moiety to the proline residue imparts an electron-withdrawing effect that drives 
the conformation of the amino acid backbone into a trans rather than a cis 
conformation.33 Because all residues in the folded triple helix must be trans, the addition 
of electron-withdrawing groups leads to peptide conformations that favor self-assembly. 
Proline and hydroxyproline are responsible for the twisting helical structure of the 
polypeptide as a result of their preferred dihedral angles. The third amino acid in the 
recurring triplet is glycine. The lack of side chain functional groups allow glycine 
residues to pack closely together at the core of the triple helix, an interaction that would 
be greatly disrupted by any amino acid substitution in this position of the peptide 
sequence. The steric interference provided by the amino acid side chain would prevent 
the close contact necessary to maintain a stable helical structure. Once the triple helix is 
formed from three individual peptide strands, multiple helices self-assemble into collagen 
fibrils and these, in tum, assemble into fibers. This organized self-assembly on multiple 
levels makes collagen-mimetic peptides a fascinating area of research. 
Synthetic collagen-like peptides can be prepared as homotrimers, in which all three 
peptide in the helix are identical, or as heterotrimers, in which there are two or three 
unique peptides in the triple helix. Heterotrimers are termed AAB if there are two unique 
types of peptides in the helix and ABC if there are three distinct peptides. When the 
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collagen X-Y -Gly template is entirely filled with proline, hydroxyproline, and glycine, 
respectively, the resulting peptide monomers self-assemble into homotrimeric triple 
helices.32 While these homotrimers are themselves useful in studying self-assembly, 
natural collagen is not homotrimeric, but rather heterotrimeric. The preparation of 
heterotrimeric triple helices has been more challenging. The Hartgerink group has 
prepared and characterized several heterotrimeric collagen-mimetic peptides, including 
the ABC-type heterotrimer composed ofthree peptides: (PKG)JO, (DOG)JO, and 
(POG)JO. 18, 19 This peptide self-assembles into triple helices (Figure 1.4) that are stable up 
to 65°C, well above physiological temperature. A second heterotrimer, an AAB-type, can 
be prepared from a 2: 1 mixture of (EOGPOG)5 and (PRG)JO and is stable up to 56°C.34 
The assembly of these systems is driven by electrostatics, although other interactions in 
the self-assembly of collagen are also being investigated. While aromatic residues are 
extremely rare in natural collagen, aromatic-aromatic interactions have been found to 
accelerate self-assembly in some collagen systems.35 
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Figure 1.4. NMR structure of (PKG) lO-(DOG)lO-(POG)lO- A) Superposition of the 15 
lowest energy conformers, where (PKG)lO is shown in blue, (DOG)lO is shown in red, and 
(POG)lO is shown in green_ B) Representation of the lowest energy conformer 
highlighting the position of charged amino acids_ C) Expanded view of two salt bridges 
observed in B with distinct conformations. Figure from reference 19_ 
The proline-hydroxyproline-glycine sequence, (POG)n, has also been used for the 
basis of modified collagen-mimetics that self-assemble into novel nanostructures such as 
peptide florettes and disks_ The Chmielewksi group has prepared microflorettes (Figure 
1.5) from triple-helical collagen-mimetics that follow this motif_ 36 In these structures, 
triple helices are assembled from (POG)9 peptides that have been modified at both 
termini with metal-chelating groups_ Upon the addition of metal ions to the system, the 
chelating groups bind the metal ions, triggering head-to-tail assembly of the attached 
triple helices_ This results in a material that assembles in microflorettes. Another (POG)-
type peptide incorporates bypyridylligands radiating from the triple-helical core. Upon 
the addition of Fe(II), the iron is complexed by bipyridine groups, which stabilizes the 
helices and results in radial self-assembly to form disks that are ~ 10 nm in height. 37 
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Figure 1.5. Self-assembly of a collagen-minetic peptide based on the (POG)n motif. This 
peptide contains nine (POG) repeats in the central region of the peptide and metal-
binding ligands at the termini. Figure from 36. 
3. Alpha Helical Coiled Coils 
Another motif that employs multiple levels of self-assembly is the alpha-helical 
coiled coil structure. The alpha helix is one of several common secondary structures 
found in proteins. Alpha helices are characterized by a twisting peptide backbone in 
which the amine proton of an amino acid in arbitrary position i interacts with the 
carbonyl oxygen of the amino acid in the i+ 3 position. This extensive hydrogen bonding 
between backbone atoms causes all of the amino acid side chains to point outward, away 
from the helical core. In the coiled coil motif, two distinct peptides, each right-handed 
alpha helices, wrap around each other to form a left-handed superhelix. This occurs when 
the hydrophobic amino acids are segregated to one side of the helix and the hydrophilic 
amino acids are segregated to the opposite side. Assembly is driven by the hydrophobic 
effect, where the hydrophobic faces of each helix pack together and the hydrophilic faces 
face outward, interacting with the aqueous environment. A coiled coil may be created if, 
in a peptide with amino acid sequence (abcdefg)n, hydrophobic amino acids are placed in 
the a and d positions and hydrophilic amino acids are placed in the e and g positions 
(Figure 1.6). In naturally occurring coiled coils, amino acids in the e and g positions have 
12 
complementary charges and participate in salt bridges.38 While many of coiled coils have 
been observed as dimers, larger helical bundles such as trimers, tetramers, pentamers, and 
d 20 hexamers have also been observe. 
Figure 1.6. Representation of an a-helical dimeric coiled coil. Residues that participate 
in hydrophobic packing are shown in black. Residues capable of forming salt bridges are 
shown in red, and hydrophilic residues are shown in green. Figure from reference 38. 
Coiled coils were first postulated by Pauling, Corey, and Crick,39,40 and have since 
been found extensively in nature, for example, in leucine zippers,41 tropomyosin,42 and 
the gp41 protein of the HIV viral envelope.43 The gp41 viral protein is a membrane-
spanning protein that contains a trimeric coiled coil at its core. The interactions between 
the helices are points of hydrophobic contact, largely with isoleucine residues, that take 
place at the a and d positions of the heptads.44 This core region of gp41 is highly 
conserved between similar viruses and is thought to be responsible for fusion of the HIV 
particle with the host cell.43 As of the 1990's, over 200 natural proteins containing coiled 
coils had been identified.45 Several of these structures are shown in Figure 1.7. 
Fos/Jun 
lFOS 
MADS box transcription factor 
lEGW 
Fibrinogen beta 
2A45 HIV-l gp41 
lAIK 
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Figure 1.7. Examples of several coiled-coil-containing proteins found in nature. Figure 
adapted from 20. 
Naturally occurring coiled coils often have deviations from the traditional heptad 
motif, which lead to disruptions in structure.20 This has led to the creation of synthetic 
coiled coils using a few basic design principles. For the creation of a coiled coil dimer 
from a peptide with repeating heptad sequence (abcdefg)n, these principles are as follows: 
first, isoleucine and leucine are the preferred residues for the a and d positions. Second, 
lysine and glutamic acid are the preferred residues for the e and g positions and form 
stable salt bridges with one another when one of each type is used. Third, hydrophobic 
residues are to be avoided in positions b, c, e, and g.20 Incorporation of these design 
features ensures maximum hydrophobic contact along the edges of the two helices, with 
additional stabilization imparted by salt bridges between lysine and glutamic acid. 
Synthetic coiled coils have found application as linkers in drug delivery,46 aids in protein 
purification,47 and in biosensors.48 
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4. Beta Sheet Structures 
The final secondary structure that is commonly observed in peptide self-assembly is 
the beta sheet. Beta sheet secondary structure arises not from intertwined peptide strands 
(as in coiled coils and triple helices), but rather from a more extended orientation of the 
polypeptide strand. In this structure, the individual atoms of the backbone occupy a 
pleated pattern, staggered evenly just above and below the long axis of the peptide strand. 
For this reason, beta sheets are often called beta pleated sheets. This backbone 
conformation is stabilized by hydrogen bonding between the backbones of adjacent 
peptide strands. In nature, beta strands are most often found hydrogen-bonded to other 
beta strands, forming a sheet-like structure. Hydrogen bonding can be parallel or anti-
parallel. In a parallel beta sheet, all peptide strands are oriented in the same way. 
Hydrogen bonding takes place between the carbonyl oxygens in the peptide backbone 
and the amide protons closest to them in the adjacent peptide backbone, although these 
atoms are offset slightly from one another. In an antiparallel beta sheet, each beta strand 
alternates orientation with the previous strand, so that the N-terminus of one peptide is 
matched with the C-terminus of peptides on either side of it. Hydrogen bonding still takes 
place between the carbonyl oxygens and amide protons but the atoms are not offset from 
one another in the plane of hydrogen bonding as they are in a parallel beta sheet. 
Peptides can assemble using the beta sheet conformation to produce a number of 
structures. One structure found frequently in nature is the beta barrel. A beta barrel is 
simply a beta sheet that is twisted so that the last strand in the beta sheet can hydrogen 
bond with the backbone of the first. The inter-strand hydrogen bonding is the stabilizing 
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force for this self-assembly, which results in a cylindrical structure that is commonly 
found within cell membranes.49 Beta barrels typically range from as few as 8 beta strands 
to 22 or more.50 Beta barrels of differing sizes can act as pores for differing molecules, 
making this motif extremely useful in biology. This provides a mechanism for creating 
toxicity. It is estimated that approximately 2-3% of the Gram-negative bacterial genome 
codes for genes with beta barrel protein products.49 Another beta-sheet-derived secondary 
structure motif is the beta hairpin. A hairpin consists of a single polypeptide containing 
two beta strands (Figure 1.8). The first strand leads to a short loop, which allows the 
peptide backbone to fold 1800 over the course of two to five amino acids, and this loop is 
connected to the second strand, another beta strand. Thus, a beta hairpin is a two-strand 
antiparallel beta sheet. The formation of beta hairpins is thought to be crucial in the early 
steps of protein folding in ViVO. 51 
Figure 1.8. The peptide VKVKVKTKVLpPTKVKTKVKV -NH2 folds reversibly into a 
beta hairpin, which can subsequently self-assemble into larger structures. Adapted from 
reference 52. 
Both beta hairpins and individual beta strands are capable of forming a number of 
nanostructures in synthetic systems. Many of these structures are high aspect ratio 
supramolecular assemblies that can be classified as nanotapes, nanoribbons, and 
nanofibers. While similar in nature, a few subtle features differentiate these structures 
from one another. It is useful to keep in mind that in beta sheet structures, one half of the 
amino acid side chains are segregated to one face of the sheet, and the other half of the 
side chains are segregated to the opposite face of the sheet. N anotapes are amphiphilic 
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structures in which one face of the tape is hydrophilic and the other face is hydrophobic. 
In anyone environment, one side of the molecule will show an affinity for a particular 
surface, similar to a piece of adhesive tape. Because the hydrophobic face would 
otherwise be exposed in an aqueous solution, nanotapes often fold into helical structures, 
even though the component peptides still reside in the beta sheet conformation. 53, 54 When 
two tape-like assemblies associate, they form a nanoribbon with a hydrophobic interior 
and hydrophilic exterior. These nanoribbons are relatively flat and display a propensity to 
twist along their long axis.8, 53 When this twist is absent, these nanostructures are termed 
nanofibers, which will be discussed in more detail in the next section. 
D. Peptide Nanofiber Self-Assembly 
Self-assembled peptide nanofibers are an excellent example of one such nanostructure 
that utilizes interactions between amino acids. A nanofiber may be defined as a long, thin 
object of high aspect ratio with dimensions on the nanoscale. Nanofibers differ from 
nanotubes in that nanofibers are not hollow, although intercalation of non-peptide 
molecules within the fibers is sometimes possible. Peptide nanofibers are useful for a 
number of reasons. Synthetic fibrous networks are capable of mimicking the extracellular 
matrix of the body. Peptide nanofibers often form hYdrogels, which can be used for drug 
and cell delivery. Finally, fibrous peptide assemblies can also indicative of disease states, 
for example, Alzheimer's disease. As a result, many self-assembling peptide nanofiber 
systems have been prepared and studied. Peptide nanofibers can generally be divided into 
three types: nanofibers derived from hybrid peptide materials (such as peptide 
amphiphiles), nanofibers derived from alpha helices, and nanofibers derived from beta 
sheets. 
1. Peptide Amphiphile Nanofibers 
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Peptide amphiphiles are another class of self-assembled peptides with novel 
properties. A peptide amphiphile consists of an oligopeptide block and an alkyl tail (with 
a 16-carbon chain, for example) that is covalently attached to the peptide portion of the 
molecule. This creates an amphiphilic molecule that, upon screening of the charges on 
the molecule at low pH, self-assembles into cylindrical micelles of uniform diameter 
(Figure 1.9). These cylindrical micelles are approximately 8 nm in diameter and microns 
in length.9 This self-assembly also results in the reversible formation of a self-supporting 
hydrogel. Driven by the hydrophobic effect and the conical shape of the molecule, the 
lipid moieties pack into the center ofthe nanofiber, which the peptide moieties remain on 
the periphery of the fiber, interacting with each other through hydrogen bonding. The 
hydrogen bonding resembles that of a parallel beta sheet, which imparts stability and 
rigidity to the nanofibers.55 This template allows some flexibility of the amino acid 
selection, and different amino acids may be incorporated into the sequence to suit a 
variety of purposes. Although not required, the incorporation of cysteine residues near the 
alkyl tail ofthe molecule imparts additional robustness to the fibers when these cysteine 
residues are oxidized to form disulfide bonds.9, 56 The sequences IKV A V (derived from 
laminin) and RGD (derived from fibronection) are cell recognition sequences that may be 
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9 57 d·fi d . ·d incorporated closer to the periphery of the assembled fiber. ' Mo I Ie amIno aCI s 
such as phosphoserine can nucleate crystals on the surface of the nanofiber. 
c 
Figure 1.9. A) Structure of a peptide amphiphile, incorporating five key structural 
features: 1 denotes an alkyl tail that imparts hydrophobicity. 2 denotes four cysteine 
residues that may be oxidized to form disulfide bonds. 3 is a linker region composed of 
three glycine residues. 4 denotes a phosphorylated serine residue that is designed to direct 
biomineralization, and 5 is the cell recognition sequence RGD. B) Model of a peptide 
amphiphile. C) Schematic of peptide amphiphile self-assembly. Figure from reference 9. 
In addition, the mechanical properties of these systems can be tuned by altering 
the amino acid selection. 55 Peptide amphiphile nanofibers have found application as aids 
in hydroxyapatite mineralization,9 central nervous system regeneration, 57 and nucleation 
of CdS nanocrystals. 58 
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2. Alpha Helical Coiled Coil Nanofibers 
Peptide nanofibers may also be assembled from coiled coils. There are a few naturally 
occurring coiled coil systems with extensive self-assembly. Intermediate filaments, for 
example, are constructed from coiled coil dimers that self-assemble to form tetramers, 
octamers, and larger structures that eventually result in filament formation. 59 These 
filaments make a significant contribution to the mechanical properties of the cell. 
Synthetic systems have brought with them the possibility of nearly infinite self-assembly 
to form nanofibers. Potekhin and coworkers have prepared a 34-amino acid peptide that 
was rationally designed to form pentameric coiled-coils.6o This peptide self-assembles 
into uniform fibers at acidic pH that are ~2.5 nm in diameter and can be hundreds of 
nanometers in length (Figure 1.10). Some systems have incorporated design elements to 
allow fiber elongation as well as lateral assembly. 
r } I 
a b c 
Figure 1.10. a) Two-dimensional representation of a five-stranded fibril. b) Structural 
model of a five-stranded fibril containing 34-residue peptides. (One strand is shown in 
blue, N-termini are in yellow). c) Model of the fibril built of pep tides with five additional 
residues (shown in yellow) of non-coiled coil sequence. The structures were modeled and 
the picture was generated by the Insight II package. Figure adapted from reference 60. 
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The Woolfson group has prepared coiled coil extended fibers from two 28-residue 
peptides.61 In this system, the individual helices in the dimer were offset from one 
another by two heptad repeats (14 residues) in order to create "sticky ends" that would 
encourage other staggered dimers to pack with the original dimer in a complementary 
manner. As this process is repeated with many staggered dimers, the fiber grows longer. 
Lateral assembly is also observed in this system, with a mean fiber width of 43 nm. The 
Woolfson group has further developed this possibility for lateral assembly in coiled coil 
nanofibers, using complementary leucine zipper coiled coils to prepare fibers that are 
more than 50 nm wide and over IO!--tm long.62 
3. Self-assembled Beta Sheet Peptide Nanofibers 
The beta sheet nanofiber is one another subgroup of self-assembled peptide fibers. In 
nature, this motif can be found in amyloid fibrils, characteristic of Alzheimer's disease. 
Alzheimer's disease is a progressive disease involving neurodegeneration and dementia, 
accounting for approximately 50 to 70% of late-onset dementia.63 Symptoms can be 
correlated with the formation of amyloid fibrils. 64, 65 There is no cure and treatment 
options are minimal. Thus, the fibrous networks found in the brain tissue of Alzheimer's 
patients provide a point of interest for studying the self-assembled beta sheet nanofiber 
structure. Amyloid fibrils are composed of beta hairpin peptides that self-assemble into 
proto filaments or protofbrils 3 nm wide, where the peptide backbone is perpendicular to 
the filament axis. This is termed a "cross-j3" structure. While these cross-j3 assemblies 
may be formed by a number of peptides, the most common peptide involved in these 
21 
structures is amyloid-~, or A~. Protofilaments of assembled A~ subsequently assemble 
into fibrils 5-10 run in diameter.65 
There are two variants of amyloid-~: a 40-amino acid and a 42-amino acid 
polypeptide, termed A~40 and A~42, respectively.66, 67 Both are derived from amyloid 
precursor protein (APP), a membrane-spanning protein whose function is not known 
despite extensive study.65,67 However, it is known that mutations in the gene for APP, as 
well as mutations in proteins that handle APP processing, can lead to earlier onset of 
Alzheimer's disease. APP is expressed in all cells and is regularly cleared from cells by 
enzymatic degradation. APP is cleaved by secretase enzymes to yield individual A~ 
fragments, which go on to self-assemble into protofilaments and then fibrils. 
Closer examination of A~ shows that the first 16 residues are disordered, while 
residues 17-42 participate in the beta hairpin that is characteristic in A~ protofibrils. This 
hairpin is composed of two parallel beta sheets derived from amino acids 18-26 (~1) and 
31-42 (~2).68 The structure of residues 17-42 is shown in Figure 1.11. 
I M35 
~ Fibril Axis 
Figure 1.11. The 3D structure of an amyloid fibril. Left: ribbon diagram of the core 
structure of residues 17-42 illustrating the intermolecular nature of the inter-~-strand 
interactions. Right: van der Waals contact surface polarity and ribbon diagram of the A~ 
protofilament. Adapted from reference 68. 
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Within these regions, several candidates have been implicated as being responsible 
for fibril nucleation. Most of these sequences include AI) residues 16-20, KLVFF. When 
added to AI) in vitro, this pentapeptide fragment exhibits strong binding to AI) and is 
capable of preventing fibril formation.69, 70 The peptide FFKL VFF is also known to self-
assemble in a beta sheet fashion to form amyloid fibers in methanol and 
trifluoroethanol.71 Several factors drive the assembly of AI) in biological systems. First, 
extensive hydrogen bonding between individual peptide backbones stabilizes the cross-I) 
fiber structure. Second, the hydrophobic effect can drive proto fibril self-assembly, as 
assembled structures shield hydrophobic residues such as leucine, valine, and 
phenylalanine from water. Finally, it has been suggested that aromatic amino acid 
residues, specifically phenylalanine, interact with each other in the self-assembled state 
via Jt-Jt stacking interactions, and that this interaction is crucial in fibril nucleation and 
growth. 
All three of these driving forces can be utilized in synthetic systems as well. Synthetic 
I)-sheet peptide nanofibers have been prepared by a variety of groups, including 
Hartgerink,21 Pochan,72 and Zhang?3 The successful design of these peptides has been 
dependent on several factors. First, most of these peptides are relatively short in length, 
containing on average 16-20 amino acids. Second, these peptides employ charged 
residues to aid in solubility. Third, the sequences of synthetic beta sheet peptides contain 
alternating hydrophilic and hydrophobic amino acids, which segregate to opposite sides 
of the beta sheet when the peptide is folded. This creates an amphiphilic molecule that 
self-assembles in predictable ways. Some beta sheet-forming peptides also employ 
aromatic-aromatic interactions, although these are not required for nanofiber self-
assembly in synthetic systems. 
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Zhang pioneered the design of peptides that form beta sheet nanofibers when his 
group recognized a sequence of alternating hydrophilic and hydrophobic amino acids in a 
DNA binding protein, zuotin. In 1993 the Zhang group reported that the 16-amino acid 
peptide [(Ala-Glu-Ala-Glu-Ala-Lys-Ala-Lys)2], termed EAK16, self-assembles in water 
to form beta sheet nanofibers.74, 75 In this system, the alternating sequence of charged 
amino acids (glutamic acid and lysine) with alanine residues creates a hydrophilic face 
and a hydrophobic face. Assembly takes place when two EAK units first form a 
sandwiched dimer, with the alanine residues on the interior and the lysine and glutamic 
acid residues on the exterior. Multiple dimers can then assemble perpendicular to the 
peptide backbone in both directions to form nanofibers. The glutamic acid and lysine 
residues on the exterior of the fiber form salt bridges that stabilize self-assembly. Later, 
EAK16 was modified to replace glutamic acid residues with aspartic acid and lysine 
residues with arginine, resulting in the peptide [(Arg-Ala-Arg-Ala-Asp-Ala-Asp-Alah], 
or RAD 16.76 Both of these peptides show a distinctive beta sheet signature via circular 
dichroism and correspondingly form nanofibers. Dried films of RAD 16 were also shown 
to support cell attachment in vitro (EAK16, however, did not). This sequence was later 
optimized to RADA16, [(Arg-Ala-Asp-Ala-Arg-Ala-Asp-Ala)2].73,77 RADA16 has been 
shown to support cell growth and attachment in vitro and has been developed 
commercially under the name Puramatrix. Puramatrix self-assembles into a hydrogel 
upon contact with cell culture media or salt solutions, and this hydrogel has since been 
used as a cell scaffold for a variety of applications.78 
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Pochan and Schneider also developed a peptide system that self-assembles into beta 
sheet nanofibers. In 2002, they reported that MAXI, a 20-amino acid peptide, 
VKVKVKVKV _DpPT -VKVKVKV -NH2, folds reversibly into a beta-hairpin 
conformation upon exposure to basic pH (Figure 1.12).72 In this system, when the pH is 
raised to 9, the lysine residues become deprotonated, eliminating the net charge of the 
peptide. Without ion-ion repulsion to discourage self-assembly, the peptide folds into a 
beta hairpin. This is encouraged by two factors. First, peptide folding into a hairpin 
allows all of the hydrophobic valine residues to be in contact with one another at the 
center of the hairpin. Valine has a particularly high propensity to form beta sheet 
structures and is thus ideally suited for this system. Second, the proline residues enable 
the peptide to form the beta turn necessary for hairpin formation. Further self-assembly 
takes place as j3-hairpin units assemble perpendicular to the hairpin axis to create long 
nanofibers, and this step is stabilized by hydrogen bonding between adjacent peptides. 
Nanofiber formation is accompanied by the transition to a viscoelastic hydrogel. 
Acidification of the solution results in the unfolding of the hairpin and the dissolution of 
extentive nanofiber network. Modifying MAXI to contain two threonine residues in 
hydrophobic positions resulted in the synthesis ofMAX3. MAX3 folds in response to an 
increase in temperature, forming a hydrogel at approximately 60°C. The peptide unfolds 
upon cooling to SoC, dissolving the nanofibers and triggering a transition from the gel 
state back to a liquid state.52 When one lysine in the MAXI sequence is changed to a 
glutamic acid residue, thereby reducing the overall charge on the peptide, the 
hydrogelation kinetics can be modified. As a result, this peptide, MAX8, forms a 
hydrogel much faster than does MAX1.79 Hydrogels formed from beta hairpins such as 
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MAX I and MAX8 experience shear thinning (one form of yielding to applied stress) and 
thus can be easily pushed through a syringe for biomedical applications. The nanofiber 
network of both peptides recovers after the shear is removed, allowing the system to 
resume a semi-solid state.80 This beta hairpin motif has been modified to include "strand-
swapping" as a method of self-assembly, a process in which one peptide forms two 
complementary structures which then dimerize and subsequently form nanofibers. 81 
Other peptides featuring the general MAX I and MAX8 motifs have been adapted to 
direct biomineralization in the presence of alkaline phosphatase. 82 
... 
Figure 1.12. Model of the proposed beta hairpin structure of peptide MAXI. MAXI 
shows reversible self-assembly to form hydrogels. Reproduced from reference 72. 
Collier and colleagues have prepared an interesting variation on self-assembling beta 
sheet peptides. Their work on the peptide QQKFQFQFEQQ, or QII, incorporates 
glutamine both as a hydrophilic and hydrophobic amino acid. The aromatic amino acid 
phenylalanine occupies the remaining hydrophobic amino acid positions in the beta sheet 
design, leading to significant aromatic-aromatic interactions in the nanofiber core. The 
hydrophilic positions utilize both lysine and glutamic acid. This peptide and several 
variations have been shown to self-assemble into beta sheets, as determined by circular 
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dichroism, and form hydrogels in the presence of salt.83, 84 While the peptide sequence of 
Q 11 itself deviates from the prototypical beta sheet template, work by the Collier group 
has demonstrated the truly modular nature of self-assembling peptides. They have shown 
that cell recognition sequences such as RGDS and IKV A V can be incorporated at the 
termini of the peptide without compromising either the fiber morphology or the 
rheological properties. In this way, they have designed extracellular matrix mimics that 
incorporate multiple cell-binding ligands.85 Peptides based on Qll have not only been 
investigated as extracellular matrix mimics,84 but also as immune adjuvants. 86 
Similar peptides, based on the repeating (FKFE) unit, have also been used to 
construct beta sheet peptide nanofibers. While distinctly different from the Q 11 sequence, 
(FKFE)n utilizes many of the same amino acids and forms similar nanostructures. 
Peptides based on this motif are derived from Zhang's EAK16 and were first pioneered 
by the Zhang, Kamm, and Lauffenburger groups at MIT. 87 They showed that (FKFE)3 
forms hydrogels at neutral pH, near the isoelectric point of the peptide.87 This sequence 
was further developed by Nilsson and colleagues into a peptide that is responsive to 
either oxidative or reductive conditions. In this peptide, C(FKFE)2CG, the cysteine 
residues on the termini of the peptide can be oxidized to form a disulfide bond between 
them, resulting in the folding of the peptide into a cyclic conformation. Upon reduction of 
the disulfide bond, the peptide unfolds into an extended conformation, which allows it to 
self-assemble into nanofibers and form hydro gels. 88 Peptides using the (FKFE)n motif 
rely on the same principles that govern self-assembly as many of the peptides previously 
discussed, although these peptides have the additional feature of utilizing aromatic-
aromatic interactions in the self-assembled state. However, it is unclear how much the 
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interactions at the center of the nanofiber are dominated by the hydrophobic effect versus 
Jt-Jt stacking. To answer this question, the Nilsson group constructed a series of pep tides 
based on the (FKFE)2 structure and examined the relative contributions of hydrophobic 
and aromatic-aromatic interactions to peptide self-assembly.89 In this series, 
phenylalanine residues were systematically replaced with alanine, valine, leucine and 
cyclohexylalanine (a synthetic amino acid that is sterically similar to phenylalanine but 
lacks aromatic character). It was found that in this series of peptides, the hydrophobic 
effect dominates over aromatic interactions, and that phenylalanine is not required for 
self-assembly into nanofibers. However, it was also observed that the peptide containing 
phenylalanine, (FKFE)2, displayed interesting concentration and solvent-mediated 
polymorphism, a feature that was not observed with any other amino acid. 
Finally, the Hartgerink group has developed a series of beta-sheet forming peptides 
called multi domain peptides (Figure 1.13). Multidomain peptides (MDPs) have two 
distinct regions: a central block consisting of a hydrophilic face and a hydrophobic face, 
and a peripheral block on each end of the peptide. The central block is composed of 
alternating hydrophilic and hydrophobic amino acids, which when in an extended beta 
sheet conformation, form the facial amphiphile that drives self-assembly. The peripheral 
blocks are composed of charged amino acids and limit self-assembly while 
simultaneously improving solubility. Self-assembly in aqueous solution is triggered by 
charge screening of these peripheral amino acids. Once the charge on these amino acids 
is neutralized, the peptides no longer repel one another and assemble into dimers, 
tetramers, and so on. The center of the oligomer contains the hydrophobic residues, 
shielded from the aqueous solvent, while the outer face interacts with water through its 
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hydrophilic residues. Multiple oligomers assemble along an axis perpendicular to the 
peptide to form extended (3-sheet. 21 
Hydrophobic!: ~ :j: ~ Hydrogen 
·Packing ~ ~~"'tj,~~Bonding " __ r • .,.. .. ' ...... _ . r 
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Figure 1.13. Schematic of self-assembly of multi domain peptides. Hydrophobic packing 
directs the formation of dimers, which then self-assemble to form fibers . Taken from 
reference 90. 
Peptides assemble antiparallel to one another, and hydrogen bonds are formed 
between adjacent peptides down the length of the nanofibers. Depending on the extent of 
assembly, results in the formation of a hydroge1.21 Multidomain peptide hydrogels also 
undergo both shear-thinning and rapid recovery after removal of the shear stress, 
providing the possibility that they can be utilized for injectable therapies. It was found 
that the specific amino acid sequence has a large impact on the strength of the gel, and 
that changes to the sequence result in predictable changes in the hydrogel properties.9o 
Changes in sequence can also have a significant impact on fiber morphology 
(unpublished work). Multidomain peptide hydrogels have been developed for such 
applications as cell scaffolds91 and drug release agents. 92 
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E. Conclusions 
Self-assembly is a process that is at work in many chemical and biological systems, both 
natural and synthetic. In nature, the effects of self-assembly may be observed in nucleic 
acid structures, lipid bilayers, and protein structures such as viral capsids, enzymes, and 
amyloid fibrils. These protein structures may incorporate a variety of peptide folding 
motifs, such as collagen-like triple helices, alpha helices, or beta sheets. We can harness 
the same noncovalent interactions that drive the formation of natural protein structures to 
construct novel synthetic systems. Indeed, synthetic systems featuring each one of these 
types of secondary structure have been created. One motif that is particularly relevant to 
this work is that of the beta sheet nanofiber. These nanofibers bear resemblance to natural 
amyloid-P fibrils and their study can lead to a greater understanding of amyloid-P fibril 
formation, as well as more immediate applications as surfactants and drug delivery 
agents. 
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Chapter 2: Sequence-Nanostructure Relationships in Multidomain Peptides 
In recent years, self-assembling peptide hydrogels have shown promise as a growing 
class of synthetic biomaterials and have been investigated in a wide variety of 
applications, including cell scaffolds l -4 and drug delivery agents.5-7 The Hartgerink lab 
has rationally designed a series of multidomain peptides based on the concept of 
molecular frustration. In a frustrated system, different portions of a single molecule have 
tendencies that oppose one another. Multidomain peptides (MDPs) have an ABA block 
motif in which the central B block is composed of a hydrophilic face and a hydrophobic 
face to give the peptide its amphiphilic nature, while the peripheral A blocks are 
composed of charged amino acids. The role of the charged A block is to increase 
solubility and control self-assembly. The A and B blocks discourage and encourage self-
assembly, respectively, creating a frustrated situation in which self-assembly is controlled 
by the environmental conditions. In the presence of salts, self-assembly of multidomain 
peptides in aqueous solution results in extended f)-sheet nanofibers, a structure that is 
stabilized by hydrogen bonding between adjacent peptide backbones along the length of 
the fiber. Assembly of nanofibers is sometimes accompanied by the formation of a 
hydrogel. 8 Their truly modular nature, which allows many design features to be 
incorporated, gives multidomain peptides an advantage over some of the other beta sheet-
forming structures previously discussed. Taking advantage ofthis modularity, the 
Hartgerink lab has been able to isolate the effects of individual amino acids on the 
resulting nanostructures. Nanofiber formation of multidomain peptides is a highly 
conserved characteristic for this design motif and is correlated with a beta sheet 
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secondary structure. However, nanofiber morphology, as well as rheological properties of 
the peptide hydro gels, can be highly sensitive to specific amino acid selection.9 
A. Sequence Tuning of Multidomain Peptides' 
First generation multidomain peptides were synthesized with a repeating glutamine-
leucine (QL) motif in the central B block of the peptide. Glutamine is a moderately 
hydrophilic amino acid featuring an amide group in the side chain. This amide group 
interacts with the solvent while the leucine residues engage in hydrophobic packing in the 
center of the nanofiber. Our lab initially prepared a series K2(QL)mK2 where m ranged 
from 2 to 6, and a second series Kn(QL )6Kn where n ranged from 0 to 4 (Figure 2.1). The 
secondary structure of the peptides was examined by circular dichroism (CD), and 
morphology was examined by vitreous ice cryo-TEM. 
* This section is based on: He Dong, Sergey E. Paramonov, Lorenzo Aulisa, Erica L. 
Bakota, and Jeffrey D. Hartgerink. Self-Assembly of Multidomain Peptides: Balancing 
Molecular Frustration Controls Conformation and Nanostructure. J. Am. Chern. Soc., 
2007, 129, 12468-12472. 
b. hydrogen bonding and fiber long axis 
/ 
hydrophobic packing 
between peptldes 
Figure 2.1. a) Primary structures of the K2 and (QL)6 series of pep tides showing the 
relative domain sizes. b) Proposed model of nanofiber self-assembly indicating 
hydrophobic packing region (blue), axis of hydrogen bonding (black), and repulsive 
positive charges (red). 
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It was found that for the K2(QL)mK2 series, all of the peptides were soluble in water at 
pH 7. Self-assembly of these peptides was triggered by charge screening with added salts, 
such as phosphate buffer. Screening of the positively charged lysine residues can also be 
achieved by pH adjustment, although initial characterization of these systems was carried 
conformation by CD, and this was accompanied by amorphous aggregates observed via 
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cryo-TEM (Figure 2.2). No nanofibers were observed. This indicates that although these 
peptides contain a short block of alternating hydrophilic and hydrophobic amino acids, 
the influence of this central block was not sufficient to overcome the charge repulsion 
provided by the four lysine residues flanking the central region. As more (QL) repeats 
were added, however, the size of the B block became sufficient to direct self-assembly 
into organized nanostructures. K2(QL)sK2 shows a weak beta sheet secondary structure 
by circular dichroism, and the cryo-TEM of this peptide shows both small aggregates and 
short nanofibers with a diameter of 5 ± 1 nm. The presence of five leucines is just able to 
balance the electrostatic repulsion of lysine, but the population is not uniform, containing 
significant fractions of both amorphous and fibrous morphologies. The appearance of 
nanofibers is believed to be due to peptide's secondary structural transition into organized 
B-sheet aggregates. K2(QL)6K2 shows a distinct beta sheet signature via CD and clear, 
individual nanofibers of uniform diameter (6 ± 1 nm), controlled length (120 ± 30 nm), 
and no amorphous aggregates by cryo-TEM. These fibers appear to be finite in length, 
however, due to the competing forces towards assembly and disassembly. With four 
lysine residues and six (QL) repeats, electrostatic repulsion is just balanced out by the 
tendency for hydrophobic packing and backbone hydrogen bonding, resulting in distinct 
nanostructures. 
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Figure 2.2. CD spectra and corresponding cryo-TEM images of the K2 series of peptides 
at neutral pH. a), b) CD and TEM ofK2(QL)2K2, c), d) CD and TEM ofK2(QL)3K2, e), f) 
CD and TEM ofK2(QL)4K2, g), h) CD and TEM ofK2(QL)sK2, i),j) CD and TEM of 
K 2(QL)6K2. 
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In this series, the number of charged residues on either side (n) was varied from 0 to 
4. When n=O, the resulting peptide (QL)6 is completely insoluble in water at any pH (it is, 
however, soluble in neat TFA). Dry TEM of (QL)6 shows dense networks of aggregated 
fibers. FT-IR shows a strong beta sheet structure, indicating that hydrophobic packing is 
indeed taking place, but without any charged residues to render the nanofibers soluble, 
any nanofibers formed are simply precipitating out of solution. Likewise, K(QL)6K is 
insoluble in water, regardless of pH. However, when the total number oflysine residues 
is increased to four (n=2), distinct, soluble nanofibers are formed (Figure 2.3). Raising 
the n to 3 results in much shorter nanofibers and the presence of amorphous aggregates, 
suggesting that the assembly and disassembly forces are once again out of balance, 
slightly favoring the disassembled state. Adding a fourth lysine residue on each side of 
the peptide (n=4) results in the absence of fibers altogether. At n=4, the CD spectrum 
begins to resemble a weak alpha helix rather than a beta sheet. 
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-~ ----.------~----------~ 
Figure 2.3. Cryo-TEM images of a) K2(QL)6K2, b) K3(QL)6K3, c) ~(QL)6~ at 1wt %, 
10mM Tris, pH 7.4. 
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3. A Prototype is born 
Of the ten peptides studied, only K2(QL)6K2 was able to consistently produce 
nanofibers with predictable dimensions and morphology. Six (QL) repeats seems to be 
the ideal number for balancing hydrophobic packing and hydrogen bonding with the 
repulsive nature of the charged lysines. 
To further investigate the structure ofK2(QL)6K2 nanofibers, oriented FT-IR 
studies were performed (Figure 2.4). This allowed us to determine the orientation of 
hydrogen bonding with respect to the fiber long axis (parallel vs. antiparallel). FT-IR 
shows a strong antiparallel component, particularly in the grazing angle mode where this 
band is enhanced, at 1692 cm -1. This confirmed the model of self-assembly predicting 
anti parallel ~-sheet orientation with the axis of hydrogen bonding parallel to the 
nanofiber and the peptide backbone oriented perpendicular to the fiber axis. 
Q) 
() 
c 
(1j 
.0 
o 
(J) 
.0 
« 
a. 
Q) 
() 
c 
(1j 
.0 
o 
(J) 
.0 
« 
b. 
1750 1700 1650 1600 1550 1500 1450 1750 1700 1650 1600 1550 1500 1450 
Wave Number (cm-1 ) 
Figure 2.4. FT-IR of the amide I and amide II region ofK2(QL)6K2: a) sample examined 
after spin coating onto a CaF 2 window with the IR beam normal to the window (and thus 
the fiber long axis) surface; b) sample spin coated onto gold mirror and examined by 
grazing angle (80°) IR. Spectra were baseline corrected and deconvoluted, shown in gray. 
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If charge repulsion is the primary force preventing aggregation of these fibers, 
increasing ion concentration or pH should increase the fiber length. To test this, samples 
ofK2(QL)6K2 were prepared in 10 mM Tris pH 7.4 with 150 mM NaCl. Cryo-TEM 
reveals fibers with length increased to 150 ± 45 nm but these samples remain soluble and 
do not gel. Increasing the NaCl concentration to 1 M resulted in a highly viscous solution 
and dramatically increased fiber length ("infinite" length) as observed by TEM. 
Exceeding the pKa of lysine at a pH of 12 effectively eliminates all charge on the peptide, 
and the peptide rapidly aggregates into a white suspension that eventually precipitates. 
Cryo-TEM of the sonicated dispersions of the high pH precipitate (Figure 2.5.c) reveals a 
dense matrix of infinite length fibers. Cryo-TEM also revealed fiber diameters of 6 nm, 
although fiber heights could not be accurately observed by this method. 
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Figure 2.5. a) K2(QL)6K2 at 1 wt % in the presence of 150 mM NaCI and 10 mM Tris. b) 
K2(QL)6K2 at 1 wt % in the presence of 1 M NaCI and 10 mM Tris. c) Cryo-TEM image 
of peptide K2(QL)6K2 at 1 wt % concentration and at pH 12. The formation of dense 
network of long fibers can be seen. d) K2(QL)6K2 at 1 wt % in 10 mM Tris at pH 7. e) 
K2(QL)6K2 at 1 wt % in 150 mM NaCI and 10 mM P04 . 
This peptide was further characterized using atomic force microscopy (AFM), which 
showed fiber heights of approximately 2 nm (Figures 2.6 and 2.7). A molecular model 
was constructed, which predicts fiber diameters of 5.4 nm and fiber heights of 1.98 nm. 
This model assumes a polyproline type II conformation for the charged lysine residues 
and an extended beta sheet conformation for (QL) repeating units. The experimental data 
appear to be in good agreement with the constructed model, indicating that self-assembly 
is proceeding in this system as expected. This peptide was later characterized by scanning 
electron microscopy, which confirmed the presence of a dense fibrous network under 
charge-screening conditions. 
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Figure 2.6. Amplitude Tapping Mode AFM images ofK2(QL)6K2 fibers deposited onto 
cleaved mica from a 0.01 % by weight solution. a) depicts a 3 !lm x 3 !lm image. b) and c) 
depict 2 !lm x 2 Ilm images, while d) and e) depict 1 Ilm x 1 !lm images. 
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Figure 2.7. Height analysis ofK2(QL)6K2 fibers deposited onto cleaved mica from a 
0.01 % by weight solution. Fibers showed heights varying from 1.85 nm to 2.29 nm, 
which is consistent the predicted height of 1.98 nm. Amplitude image in figure 2.6.a 
corresponds to height image 2.7.a. Amplitude image in figure 2.6.b corresponds to height 
image 2.7.b and c. Amplitude image in figure 2.6.c corresponds to height image 2.7.e. 
Amplitude image in figure 2.6.d corresponds to height image 2.7.d. Amplitude image in 
figure 2.6.e corresponds to height image 2.7.f. 
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When the charges on lysine residues are screened by multivalent ions such as 
phosphate, a clear hydrogel is formed. Phosphate ions serve to physically crosslink the 
lysine residues, as multiple lysines can undergo charge screening by a single phosphate 
ion. These hydro gels are weak upon formation and appear to strength over time, reaching 
an elastic modulus of 95 Pascals (Figure 2.8) when the peptide is screened in a phosphate 
buffer. This observation was investigated by cryo-TEM, and it was found that over time, 
the fibers appeared to undergo a lengthening process (Figure 2.9). During this aging, the 
maximum fiber lengths do not change. However, the average lengths increased, owing to 
the disappearance of shorter fibers . 
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Figure 2.8. Strain sweep of a 1 wt% P04- gel ofK2(QL)6K2. The elastic modulus (G') is 
shown in red and the loss modulus (G") is shown in blue. 
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Figure 2.9. Aged samples ofK2(QL)6K2: a) 0.5% by weight b) 1 % by weight. The image 
in panel a was prepared from a 1 % by weight solution that was diluted 1: 1 with 10 mM 
Tris buffer immediately before cryo-TEM sample preparation. 
Analysis by dynamic light scattering (DLS) supports this finding. This 
"maturation" has been observed in other nanofiber systems as well lO and indicates that 
the initially formed nanofiber structure is not the global thermodynamic minimum and 
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that the system is still moving toward equilibrium, which is composed of larger or 
bundled fibers. 
B. Hydrophilic amino acid modification 
Alteration of the hydrophilic amino acid in the central block provides the opportunity 
to manipulate the delicate balance of molecular forces governing the self-assembly of 
multidomain peptides. The most conservative substitution, a glutamine to asparagine 
substitution, results in the peptide K2(NL )6K2, which forms nanofibers with similar 
morphology to K2(QL)6K2 (Figure 2.10). Both glutamine and asparagine contain amide 
groups in their side chains and differ only by a single methylene group. Therefore, it is 
not surprising that self-assembly of the two systems proceeds in a similar manner. 
Figure 2.10. K2(NL)6K2 forms short nanofibers as observed by AFM. Image shown is 2 
Jlm x 2 Jlm. 
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Substitution of glutamine residues with another neutral alternative, serine, results in a 
different network of hydrogen bonding between peptide strands and between the 
nanofibers and the aqueous solvent.9 K2(SL)6K2 undergoes a greater extent of peptide 
self-assembly than K2(QL )6K2 under identical conditions. K2(SL )6K2 is clearly a beta 
sheet as seen by circular dichroism, with a clear maximum at 198 nm and minimum at 
217 nm. FT-IR also indicates a beta sheet conformation (Figure 2.11). 
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Figure 2.11. a) CD ofK2(SL)6K2. The green line indicates a 1 wt% pH 7 solution and the 
blue diamonds indicate a 1 wt% P04- gel. b) FT-IR ofK2(SL)6K2. 
Fiber lengths are also longer as observed by cryo-TEM. The fiber heights, however, 
appear to be smaller than in its glutamine counterpart, approximately 1.6 nm. This is 
reasonable, considering that the serine side chain is significantly smaller than the 
glutamine side chain. Perhaps the most striking differences between the two peptides, 
however, are not in the fiber morphology but in the rheological characteristics of the 
hydrogels. K2(SL)6K2 forms a robust hydrogel nearly immediately upon contact with 
phosphate ions, while the K2(QL)6K2 gel forms over the course of hours or even days. 
Likewise, the aging phenomenon observed in K2(QL)6K2 is not noticeable in K2(SL)6K2. 
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These observations indicate that the introduction of serine (and the resulting changes to 
the hydrogen bonding network) changes the kinetics of fiber formation. K2(SL)6K2 forms 
a robust gel in both phosphate alone and in phosphate-buffered saline (PBS) with a G' of 
approximately 395 Pa in 10 mM phosphate (Figure 2.12). 
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Figure 2.12. Strain sweep of a 1 wt% P04- gel ofK2(SL)6K2. The elastic modulus (G') is 
shown in red and the loss modulus (G") is shown in blue. 
The impressive rheological properties of K2(SL )6K2, namely the high G' and ability 
to recover after shearing events, have made it an attractive system for biological 
applications, including drug and growth factor release. 
The next logical modification is to replace serine residues with threonine residues, an 
amino acid that is similar to serine but features an additional methyl group. K2(TL)6K2 
shows a distinctive beta sheet structure in circular dichroism. However, in the absence of 
salts, nanofibers are not observed by AFM. Under typical gelation conditions (10 mM 
phosphate buffer), this peptide shows a G' of approximately 635 Pa. This indicates that 
the quality of hydrogen bonding between hydrophilic amino acids and between these 
residues and the solvent is crucial to the rheological properties of the gel. 
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c. Hydrophobic amino acid modification 
It has been shown that the selection of hydrophilic residues within the central block of 
the peptide can have an enormous impact on the self-assembly processes at work. It was 
then investigated whether hydrophobic amino acid modification might also impact the 
self-assembly of multidomain peptides. In fact, the hydrophobic domain of the peptide 
offers the opportunity to introduce a new noncovalent interaction when aromatic amino 
acids are employed: 3t-3t stacking. 3t-3t stacking can occur when two aromatic amino acids 
reside in close proximity to one another, as might happen during hydrophobic packing in 
the center of a nanofiber. Therefore, the specific effects of aromatic amino acids on 
multi domain peptide self-assembly are of particular interest. 
Synthetic peptides containing aromatic amino acids have been previously shown to 
have novel self-assembly propertiesY-15 The contribution of phenylalanine residues in 
particular is of interest because phenylalanine residues are prevalent in amyloid f3, a 
protein that plays a crucial role in the development of Alzheimer's disease. Symptoms of 
Alzheimer's disease are correlated with soluble fibrils assembled from amyloid f3.16 In 
these structures, the individual beta sheet peptides (amyloid f3 or A(3) assemble so that the 
peptide backbones are perpendicular to the fiber axis,17 much like in our system. It has 
been determined that a short region of the amyloid f3 protein is essential for the 
nucleation of self-assembled amyloid f3 fibrils. This region includes residues Af3 16-20, 
KL VFF. When added to Af3 in vitro, KL VFF exhibits strong binding to Af3 and is 
capable of preventing fibril formation. 18,19 The peptide FFKL VFF is also known to self-
assemble in a beta sheet fashion to form amyloid fibers in methanol and 
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trifluoroethano1.20 While the presence of phenylalanine in amyloid 13 appears to be crucial 
to fibril nucleation,21 its exact contribution is still being investigated. Efforts to 
synthetically recreate amyloid l3-like fibrils have lended support to the importance of 
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shown to encourage fibril nucleation in other natural systems as well, such as in type I 
collagen?3 Elucidating the specific effects of aromatic amino acids on self-assembly in a 
more analogous system, a multidomain peptide system, may have important implications 
for the nucleation of amyloid 13 self-assembly as well. However, one problem that 
remains to be solved is whether the changes in self-assembly in systems incorporating 
aromatic amino acids are due to the aromaticity, hydrophobicity, or steric influence of 
these amino acids. 
Here we examine the substitution of leucine residues of multidomain peptides with 
the aromatic residues phenylalanine, tyrosine, and tryptophan residues. Each substitution 
affects a noticeable impact on the morphology and rheology of peptide hydro gels formed 
by these peptides. The number and type of charged residues was kept constant to examine 
the effect of the hydrophobic amino acid alone. 
1. Secondary Structure 
The effect of the hydrophobic amino acid on the circular dichroism of these peptides 
is significant. While K2(QL)6K2 shows a typical beta-sheet conformation via circular 
dichroism (CD), substitution of aromatic amino acids introduces new features into the 
CD spectra of these peptides (Figure 2.13). Each peptide was observed in both the gel 
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and non-gelled state, since the nature or extent of self-assembly may change in the 
presence of ions. Hydrogels were formed by dissolving lyophilized peptide at 2 wt% in 
ultrapure water and adding an equal volume of 20 mM phosphate buffer at pH 7. 
Solutions were mixed by careful pipetting, which resulted in a 1 wt% gel. Non-gelled 
peptides were dissolved at 1 wt% in ultrapure water and adjusted to pH 7. CD and IR 
spectra did not differ significantly between the non-gelled and gel states. K2(QF)6K2 
shows a distinct minimum in its CD spectrum at 200 nm, and the characteristic maximum 
has shifted from 200 nm to 191 nm. The minimum characteristic of beta sheets is still 
present but has shifted slightly to 214 nm. This minimum around 200-205 nm has been 
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intensity of this minimum may introduce artifacts in that it may cause other maxima or 
minima to appear red- or blue-shifted even through a structural transition has not taken 
place. Other Phe-containing peptides have been shown to have anomalous CD spectra as 
well. 25 In fact, peptides displaying such unusual CD features are determined through 
other techniques to still have j3-sheet characteristics. 13, 24 In order to ascertain the extent 
to which the phenylalanine residues actually disrupt the j3-sheet structure, the peptide 
K2(QFQL)3K2 was constructed. Designed to be an intermediate between K2(QL)6K2 and 
K2(QF)6K2, this peptide shows a clear j3-sheet conformation via CD, with a maximum at 
201 nm and a minimum at 220 nm, indicating that the simple presence of an aromatic 
amino acid in the sequence is insufficient to destroy j3-sheet structure in this system. 
Thus, a structural transition has not taken place with the introduction of phenylalanine. In 
fact, when the hydrophobic amino acid is changed to a tyrosine or tryptophan, we see a 
return of a more typical j3-sheet spectrum, and this minimum at 200 nm is not present, 
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although the peak shape of the maximum between 190 and 200 nm is clearly altered. 
Infrared (IR) spectroscopy of all peptides suggests ~-sheet secondary structure. 
Therefore, aromatic amino acids in the central block of multi domain peptides make a 
significant contribution to their CD spectra but do not preclude ~-sheet formation. It is 
suspected that the minimum at 200 nm distorts the spectrum but that the deviation from a 
beta sheet secondary structure may be minimal. 
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Figure 2.13. CD spectra and corresponding FT-IR of pep tides incorporating varying 
amounts of phenylalanine. a, b) CD and IR ofK2(QL)6K2, c,d) CD and IR of 
K2(QFQL)3K2, and e,f) CD and IR ofK2(QF)6K2. Red lines (- ) indicate the solution 
state. Blue diamonds (.) indicate the P04- (a,c,e) or PBS (b,d,f) induced gelation state. 
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The tryptophan and tyrosine analogs of these peptides, K2(QW)6K2 and 
K2(QY)6K2, show a more typical beta sheet CD spectrum (Figure 2.14). Collectively, it 
can be concluded that multidomain peptides with the sequence K2(QX)6K"2, where X is an 
aromatic amino acid, have a predominantly beta sheet secondary structure. While peak 
shapes of these multi domain peptide spectra may be distorted, all peptides examined here 
except K2(QF)6K2 display maxima and minima at the expected values for a beta sheet. 
K
2
(QW), K1 ca~o .-~---.--.---.-~--~~ 
~-30 r-~~-~---~--~-+--~--~ ~ '§ 20 t--~>-~ 
go X ~ '71/) 10 25 ~ ~ ~ ~ ~ 0 ~---+--+,~.+--+----;...-+-_ ... 1IIIIIIt ~ £ "0 ~ 
~ (\/§-10 
~ ~ 
~-20 
·30 ::--:-±=--~--::~-=~--:+,,--...,..L,,----l 180 190 200 210 220 230 240 250 
Wavelength (nm) 
b K (ow> K 2 • 2 r----------, 
1750 1700 1650 1600 1550 1500 1450 
Wavenumber (em1) 
Kz(QY), K1 C.20 r-~--~~.---'-~--~~ d K (OY> K 2 6 2 .r----- - - ---, 
'7§-15 r-~--1~~--r-~--.~~ :z. 
<:5 g ~ 10 r--+~~~~--~-+--~~ Q) 
m '7 <..) 
Q) ~ C 
:3 .. 5. ('() ~ ~ ~:-+--f~1l ~ 
~ "0 ~ ~ N§ 0 rl~-t;;ll;- t--+\: ____ f---+-.... IIIIiI:IIII~ <t 
~ !.5 ~~.~-r--+-~~~+--~~ 
-1 0 ~--;-;;;:---::±::--::~-=!:-=--::+'::--."..L,...---,-J 180 190 200 210 220 230 240 250 
Wavelength (nm) 
1750 1700 1650 1600 1550 1500 1450 
Wavelength (em1) 
Figure 2.14. CD spectra and corresponding FT-IR of pep tides incorporating tyrosine and 
tryptophan. a, b) CD and IR ofK2(QW)6K2, c,d) CD and IR of 5. Red lines (- ) indicate 
the solution state. Blue diamonds (+) indicate the P04- (a,c) or PBS (b,d) induced 
gelation state. 
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Previous studies of multidomain peptides found the peptide strands within the 
nanofibers to be oriented antiparallel to one another. Grazing angle IR experiments were 
performed in order to determine the preferred orientation of hydrogen bonding within the 
nanofiber.26 In this set of experiments, an IR spectrum of the peptide sample on a CaF2 
window is taken, with the beam perpendicular to the sample. This is compared to a 
second sample, which is dried onto a gold mirror that is placed nearly parallel to the 
beam. Because the IR beam is oriented differently relative to the sample in both cases, 
the two sets of spectra can reveal information related to directional interactions within the 
peptide nanostructure.26, 27 A peak at 1695 cm-1 in the grazing angle spectrum is 
characteristic of an anti parallel beta sheet. This peak is present in grazing angle spectra 
for K2(QL)6K2, K2(QFQL)3K2, and K2(QF)6K2 (Figure 2.15). However, no obvious peak 
is visible for peptides K2(QW)6K2 or K2(QY)6K2. Therefore, it is possible that 
K2(QW)6K2 and K2(QY)6K2 adopt a parallel beta sheet conformation, while K2(QL)6K2, 
K2(QFQL)3K2, and K2(QF)6K2 reside preferentially in an antiparallel orientation. 
Modeling simulations are currently being undertaken to investigate the preferred packing 
nature of each of these peptides. 
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Figure 2.15. Grazing angle IR spectra of a) K2(QL)6K2 (red), K2(QFQL)3K2 (blue), and 
K2(QF)6K2 (green). Note the presence of a distinctive peak between 1690 and 1700 cm- I . 
b) K2(QW)6K2 (blue) and K2(QY)6K2 (green). 
2. N anofiber morphology 
Fiber network morphology was examined for all peptides in both the gelled and non-
gelled states. Gelation conditions were achieved by the addition of charge-screening salts. 
For a peptide with positively charged lysine residues on the termini, a negatively charged 
multivalent salt, such as phosphate, is required. Use of a multivalent rather than a 
monovalent salt allows phosphate ions to physically cross-link peptides to one another, 
leading to gel formation. For the non-gelled state, AFM and vitreous ice cryo-
transmission electrom microscopy (cryo-TEM) were used to visualize nanofiber 
morphology (Figure 2.16). For the gelled state, cryo-TEM and SEM were employed for 
this purpose (Figure 2.17). K2(QL)6K2 self-assembles into linear nanofibers that are 6 nm 
in width, 2 nm in height, and several hundred nanometers in length, as determined by 
cryo-TEM and AFM. SEM confirms the presence of a nanofiber network in the gelled 
state. The introduction of three phenylalanine residues, as in K2(QFQL )3K2, results in 
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conservation ofnanofiber formation. Nanofibers of this peptide appear linear and 
unbranched by cryo-TEM and AFM. SEM on a critical point dried gel reveals a spongy 
nanofiber network. However, the presence of six phenylalanine residues, K2(QF)6K2, 
results in very fragile fibers that are only briefly visible during imaging via electron 
microscopy. Spherical aggregates are visible via cryo-TEM in the non-gel state, along 
with some isolated short fibers. AFM supports this observation, showing the presence of 
spherical aggregates in the non-gel state. Fibers in the absence of ions were obtainable 
using these two methods. However, cryo-TEM of the peptide gel did show nanofibers. 
SEM of this peptide proved difficult, with fiber samples rapidly decaying under the 
electron beam, but fiber morphology in these gels was still observed. Interestingly, 
concentration dependent polymorphism of a similar phenylalanine-containing peptide has 
been reported previously,13 which is in agreement with our observations. K2(QW)6K2 and 
K2(QY)6K2 exhibit less fragility than the phenylalanine analog but have very different 
morphologies: K2(QW)6K2 results in linear fibers via both cryo-TEM and AFM, while 
K2(QY)6K2 shows fiber branching by both methods. 
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Figure 2.16. AFM and cryo-TEM of pep tides in the non-gelled state. a, b) K2(QL)6K2, c, 
d) K2(QFQL)3K2, e, f) K2(QF)6K2, g, h) K2(QW)6K2, i, j) K2(QY)6K2. 
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Figure 2.17. Cryo-TEM and SEM of pep tides in the gelled state (PBS). a, b) K2(QL)6K2, 
c, d) K2(QFQL)3K2, e, f) K2(QF)6K2, g, h) K2(QW)6K2, i, j) K2(QY)6K2. 
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3. Rheology 
Hydrogels of each peptide were prepared by dissolving the peptide at 2 wt% in 
ultrapure water at pH 7. To this solution was added an identical volume of2x phosphate 
buffered saline (PBS) at pH 7. The solution was pipetted up and down several times 
before the vial was capped and vortexed for several seconds. The gels were stored in 
airtight vials until rheometry was performed. Gels were examined by a strain sweep at a 
constant frequency of 1 rad/sec (Figure 2.18), as well as a shear recovery experiment. In 
the recovery experiment, gels were held at a low degree of strain for 10 minutes, then 
sheared at 100% strain for 1 minute, and subsequently returned to the low strain 
condition for an additional 20 minutes. Of the aromatic amino acid-containing peptides, 
K2(QF)6K2 showed the highest elastic modulus (G') values. K2(QFQL)3K2 and 
K2(QW)6K2 also form rigid hydrogels. Interestingly, K2(QY)6K2 only forms a weak, 
unstable gel that phase separates with time. This gel is opaque rather than transparent, 
even immediately following gel formation. It is thought that the hydroxyl group present 
on the tyrosine residues may disrupt the largely hydrophobic environment in the interior 
of the nanofibers. This is supported by the fact that K2(QY)6K2 is the least soluble of the 
peptides tested (though it is soluble at 1 wt% at pH 7). It is interesting that while the 
presence of nanofibers is often correlated with hydrogel formation in many peptide 
systems, this correlation is not clear for multidomain peptides, as K2(QF)6K2 forms a gel 
but shows poor fiber formation, while K2(QY)6K2 consistently forms fibers but does not 
form a strong gel. The reason for the lack of gel formation in K2(QY)6K2 is unclear. 
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Figure 2.18. Strain sweep ofK2(QX)6K2 phosphate and PBS gels. Phosphate gels were 
made using 10 mM phosphate buffer at pH 7.4, and PBS gels were made using PBS at 
pH 7. Asterisks indicate a peptide hydrogel that is not time-persistent. 
4. Aromatic Character Impacts Self-Assembly 
Bowerman and colleagues determined that it is largely hydrophobicity, and not 
aromaticity, that drives the self-assembly of beta sheet forming peptides into amyloid-like 
nanofibers 13. However, the modular nature of multi domain peptides allows us to explore 
the aromatic contribution to self-assembly by keeping all other blocks of the peptide 
constant. When the charged and hydrophilic residues are held constant, substitution of 
aromatic amino acids for hydrophobic leucine residues has a huge impact on fiber 
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morphology and rheology. Hydrophobicity alone cannot account for these differences,28 
as leucine and phenylalanine have similar hydropathy indices but produce vastly different 
fiber morphologies. Similarly, tyrosine and tryptophan have similar hydropathy indices 
but different fiber morphologies. However, several trends are noticeable. A multi domain 
peptide with exclusively leucines in the hydrophobic positions forms uniform, linear 
fibers. As the number of phenyl ala nines introduced increases, the less linear (and more 
disordered) the fibers become. K2(QFQL)3K2 demonstrates a consistently linear fiber 
network as observed by cryo-TEM. Thus, the presence of phenylalanine is not sufficient 
to control fiber morphology. However, K2(QF)6K2 forms a highly branched network 
under gelation conditions and only spherical aggregates in the solution state. This 
represents a large deviation from the gelation behavior and fiber morphology of 
K2(QL)6K2 and K2(QFQL)3K2. This highly disordered fiber network is also characteristic 
of gels constructed from K2(QY)6K2. This would suggest that as the aromatic character of 
the fiber interior increases, the less ordered and more branched the nanofiber network 
becomes. There is one caveat, however: K2(QW)6K2 forms extremely linear fibers in the 
solution state and somewhat linear fibers under gelation conditions. It has been shown 
previously that tryptophan-tryptophan interactions within a beta hairpin structure promote 
stable nanostructures and that the tryptophan residues within these nanostructures reside 
in an edge-to-face conformation?9 Either the additional steric bulk or the increased 
aromatic character of tryptophan as compared to the other amino acids has changed the 
preferred packing of pep tides within the fibers, resulting in stable, linear fibers. However, 
this renders K2(QW)6K2 different from all other exclusively aromatic multidomain 
peptide analogs, and the reasons for this are still under investigation. 
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D. Conclusions 
The assembly of multi domain peptides into organized fibers can be attributed 
primarily to three types of interactions. First, hydrophobic packing of leucine side chains 
is the primary thermodynamic driving force for assembly in water, but does not provide 
control over shape or structure. Second, backbone ~-sheet hydrogen bonding also 
contributes to the stability of the assembly but is more important in directing the 
anisotropy of the structure. Third, these forces are opposed by electrostatic repulsion 
between lysine side chains. As one changes the ratio between the number of hydrophobic 
residues and charged residues one may shift the equilibrium toward either self-assembly 
or disassembly. Therefore, fabrication ofnanofibers with controlled-length becomes 
possible when the driving force of the self-assembly of (QL) subunits and opposing 
charge repulsion forces are balanced. On the basis of these results, when the number of 
lysine residues on each terminus is 2, the presence of 5 or more (QL) repeats results in 
controlled self-assembly to form nanofibers. 
Modification of both the hydrophilic and hydrophobic amino acids is possible and has 
been investigated. Substitution of glutamine with asparagine or serine preserves the 
ability of the peptides to form fibers. Peptides containing serine as the hydrophilic amino 
acid also formed excellent hydrogels with an elastic modulus approximately four times 
higher than that for the glutamine analog hydrogel. This is an indication of a change in 
the magnitude or type of hydrogen bonding taking place along the length of the fibers. 
Substitution of the hydrophobic leucine residue with aromatic amino acids leads to 
interesting changes ifnanofiber morphology and gel rheology. The introduction of 
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phenylalanine is correlated with artifacts in the CD spectra, although it is thought that 
peptide folding does not deviate significantly from a beta sheet conformation. While the 
presence of phenylalanine does not preclude beta sheet formation, phenylalanine 
multidomain peptide analogs possess unexpected nanofibers morphologies that may be a 
result of an altered self-assembly process. Furthermore, while previous studies have 
shown that hydrophobicity is the driving factor in the formation of nanofibers with a 
hydrophobic core,13 there seems to be no correlation between the hydrophobicity of the 
aromatic amino acid side chain and nanofiber morphology. The lack of consistent trends 
within this family of aromatic multidomain peptides suggests that another factor, such as 
the steric demands imposed by bulky amino acids such as phenylalanine and tryptophan, 
is also exerting influence over the self-assembly process and the resulting fiber 
morphologies. 
E. Experimental 
Peptide Synthesis and Purification. The syntheses of the peptides were carried out on 
an Advanced Chern Tech Apex 396 peptide synthesizer using general procedures for 
Fmoc solid phase chemistry with HBTU, HoBt and DIEA as coupling reagents based on 
a 0.15 mmol scale. A Rink Amide was used to generate an amide group on the C-
terminus of the peptide. After completion ofthe peptide synthesis, the N-termini of 
peptides were acetylated in the presence of excess acetic anhydride and 0.9 mmol of 
DIEA in DCM. Peptides containing QL repeats were then cleaved and deprotected with a 
mixture ofTFN triisopropanolsilane Iwater/anisole (18: 0.7 : 0.7 : 0.7 by volume) for 3-4 
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hours. Peptides containing SL repeats were cleaved with a mixture of 
TFAItriisopropylsilane/water/anisoleIEDT (18: 0.5 : 0.5 : 0.5 : 0.5 by volume) for 3-4 
hours. After rotary evaporation, the residual TF A solution was triturated with cold diethyl 
ether and dried under vacuum for 24 hours before further purification. 
Mass spectrometry. A mass spectrum of the crude peptide product was obtained 
following each synthesis. This was performed on a Bruker Autoflex mass spectrometer in 
positive ion mode. Spectra were processed using FlexAnalysis software. 
Peptide Purification. Purification was done on a Varian PrepStar220 HPLC using a 
preparative reverse phase C-18 column with a linear water/acetonitrile gradient (each 
containing 0.05% TFA) at a flow rate of 14 mLimin. The UV absorption of the eluents 
was monitored at 230nm. In the event of a single product in the crude product (as 
observed by mass spectrometry), purification was achieved by dissolving the peptide at 
10 mg/mL in ultrapure water, followed by pH adjustment with NaOH to achieve a pH of 
7. The peptide solution was then dialyzed through a SpectraPor dialysis membrane for 
48-72 hours. During this time the water was changed - 2 times per day. The solution 
containing the peptide was frozen and then lyophilized to collect the pure peptide. 
Circular Dichroism Measurements. CD spectra were recorded on a Jasco-J81 0 
spectropolarimeter using quartz cells with path lengths varying from 0.01 cm to 0.001 
cm. Spectra were collected at 25°C from 250 nm to 180 nm with a 0.2 nm interval at a 
rate of 50 nmlmin. Millidegrees of rotation were converted to mean residual ellipticity. 
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FTIR measurements. Aliquots of peptide sample were pipetted onto a CaF2 window 
or gold mirror and dried under nitrogen. Grazing angle FT-IR spectra were recorded with 
a 80Spec specular reflectance accessory (pIKETechnologies). Both samples were then 
examined using a Jasco FTIR 660plus. Collected spectra were linear baseline corrected. 
By changing the orientation of the incoming IR beam with respect to the peptide 
nanofibers, one can achieve enhancement / attenuation of one mode over the other, which 
allows us to discern the orientation of peptide backbone and the intermolecular hydrogen 
bonding with respect to the nanofiber network. 26 In the case of the grazing angle IR 
experiment, where the IR incoming beam is nearly parallel to the substrate surface the 
amide I (primarily a stretching of C=O) and NH stretching modes were attenuated 
relative to the amide II mode (in plane NH bending and CN stretching). In contrast, when 
the IR beam is perpendicular to the fibers as is the case when they are deposited on the 
CaF2 window, the amide I band and NH stretching modes are enhanced relative to the 
amide II. This indicates that the hydrogen bonding is parallel to the nanofiber axis with 
peptide backbone running perpendicular to the fiber axis, which is described as a "cross-
beta sheet" conformation. Also, the enhancement of amide I peak at 1692 cm-1 in grazing 
angle IR versus transmission IR clearly demonstrates the anti-parallel orientation of beta 
sheets. 
Vitreous Ice Cryo-TEM Vitreous ice cryo-TEM samples were prepared according to 
the general procedure published by Milligan et. al,30 using a controlled environment 
vitrification system (Vitrobot, FEI). 3-6 ~L of sample were pipetted onto a holey carbon 
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grid (Quantifoil Rl.2/1.3) and gently blotted for 2 seconds resulting in a thin film on the 
surface of a carbon grid. The sample then was plunged into liquid ethane to vitrify the 
remaining water. The sample obtained was transferred on the cryoholder (Gatan 626DH) 
using a Gatan workstation and observed on the JEM 2010 microscope at -176 °e, 
equipped with eeD camera (Gatan 2x2K). 
Atomic Force Microscopy. 10 ~L ofa 0.01 wt% solution of peptide at pH = 7 were 
dropped onto freshly cleaved mica while spinning on a Headway Research, Inc. Photo-
resist spinner. The sample was spun for 10 minutes and then rinsed with deionized water 
for 1-2 seconds. The sample was spun for an additional 10 minutes and then stored at 
room temperature prior to imaging. AFM images were collected in air, at ambient 
temperature, on a Digital Instruments Nanoscope IlIa in tapping mode. 
Rheometry. A TA Instruments AR-G2 rheometer was used to perform measurements 
on all peptides. A parallel plate geometry with 8 mm diameter and 250 ~ gap was used 
for all experiments. The gels were placed carefully in the headspace with a spatula, and 
the geometry was then lowered to the preset gap. Oscillatory strain sweeps were 
performed at 25°e at a fixed angular velocity of 1 rad/s. Oscillatory frequency sweeps 
were performed at 25°e using a fixed strain of 0.5%. 
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Chapter 3: Covalent Modification of Multidomain Peptides 
The rheological properties of any matrix, natural or synthetic, playa key role in 
determining the ease of handling of the material and, in some cases, the response of the 
cells in contact with the gel. l -3 We have shown that careful amino acid selection can lead 
to different hydrogel properties in peptides. However, improvements in gel strength can 
be achieved not only through amino acid sequence modification, but also through 
covalent modifications of a multidomain peptide hydrogel network. These covalent 
modifications may be chemically or enzymatically derived. The most obvious choice for 
covalent chemical modification of peptides is the incorporation of cysteine residues, 
which may be cross-linked to form disulfide bonds under oxidizing conditions (Figure 
3.1). While cysteine oxidation allowed the tuning of the storage modulus (0') from 100 to 
over 5000 Pa,4 cysteine has proven particularly difficult to handle, as its oxidation state is 
challenging to control. Thus, an alternate method of oxidation was desired. 
l-S-H H-S-l ... i-S S-i 
Figure 3.1. The oxidation of cysteine side chains to form a disulfide bond. Only the 
terminal -SH groups of the cysteines are shown. 
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A. Enzymatic Cross-linking-
The possibility of enzymatic cross-linking of residues within a peptide hydrogel 
solves many of the difficulties in handling introduced by cysteine, while simultaneously 
providing an option with a potential for high biocompatibility. In nature, components of 
extracellular matrix, such as collagen and elastin, are cross-linked by lysyl oxidase (LO), 
which oxidizes the primary amine of lysine to an aldehyde. This aldehyde can 
spontaneously react with another amine to form a Schiff base (Figure 3.2) or undergo an 
aldol condensation with another aldehyde.5,6 Here we show that K2(SL )6K2, which 
contains four lysine residues, is able to be cross-linked by either lysyl oxidase (naturally 
found in serum-supplemented medium) or plasma amine oxidase (P AO, a similar and 
commercially available enzyme which also functions by oxidation of primary amines). In 
either case, cross-linking results in a dramatically increased storage modulus over time. 
~+ I Schiff~ase ~ , Formation o ""'('" -N 
Figure 3.2. Proposed scheme of chemical cross-linking induced by lysyl oxidase or 
plasma amine oxidase. 
* This section is based on: Erica L. Bakota, Lorenzo Aulisa, Kerstin M. Galler, and 
Jeffrey D. Hartgerink. Enzymatic Cross-Linking of a Nanofibrous Peptide Hydrogel. 
Biomacromolecules, 2011, 12 (1), 82-87. 
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That K2(SL)6K2 could be oxidatively cross-linked was a serendipitous discovery. As 
the biocompatibility of various MDP hydrogels was investigated, it became apparent that 
gels composed ofK2(SL)6K2 that were incubated with dental stem cells,7 experienced a 
significant increase in storage modulus (G') over time. This study revealed that the G' 
increased over fourteen days of cell growth to ~6000 Pa (Figure 3.4a, blue bars). 
Histological sections of the cell / hydrogel composite indicated substantial production of 
natural extracellular matrix (data not shown). Based on these findings, we hypothesized 
that the newly synthesized ECM was responsible for the increase in mechanical 
properties, a phenomenon that had also been reported in the literature for similar 
systems.8,9 In contrast, parallel experiments run with E2(SL )6E2, which differs from 
K2(SL )6K2 in that it uses the negatively charged amino acid glutamate in the peripheral 
region to control self-assembly rather than the positively charged amino acid lysine, were 
found to decrease in G' over time. In an attempt to understand the difference between 
these peptides further, a control experiment was run under identical conditions but 
without cells using K2(SL )6K2. Surprisingly, gels prepared from K2(SL )6K2 showed a 
similar increase in G' over time despite the absence of cells (Figure 3.4a, red bars). 
Clearly, production of extracellular matrix was not the cause of the G' increase. To 
identify the cause of this effect, K2(SL)6K2 was incubated under several different 
conditions including: phosphate buffered saline (PBS), cell medium, cell medium 
enriched with Fetal Bovine Serum (FBS) and FBS alone (Figures 3.3a and b). In the 
absence ofFBS, K2(SL)6K2 did not display an increase in G'. However in the presence of 
FBS, G' increased dramatically. These experiments demonstrated that a component of the 
serum, and not production of ECM (or any other cellular component) was responsible for 
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the increase in 0'. Unfortunately, fetal bovine serum contains a wide array of components 
and has been surprisingly poorly characterized. Additionally, the increase in 0' did not 
take place with E2(SL )6E2. Because the increase in 0' was seen in only one multi domain 
peptide, and because FBS alone does not form hydrogels, it can be determined that it is 
the combination of a serum component and a multidomain peptide that together 
contribute to an increase in elastic modulus. Because the difference between the two 
peptides is the presence ( or absence) of lysine, it can also be concluded that lysine is a 
required component of the peptide. 
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Figure 3.3. Strain sweeps ofK2(SL)6K2 under various medium compositions. a) no 
inhibitor after 10 days of treatment except FBS which is after 14 days treatment. b) after 
10 days of treatment with FB S and indicated concentrations of ~APN. c) after 10 days of 
treatment with PBS only and after 10 days of treatment with PAO and ~APN. d) after 1, 
4, 7 and 15 days treatment with PAO. 
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Figure 3.4. a) Storage modulus ofK2(SL)6K2 over 14 days with dental stem cells in 
presence of medium enriched with 10% FBS (blue) or medium enriched with 10% FBS 
with no cells (red). In all cases, one half the supernatant was refreshed every two days. b) 
K2(SL )6K2 incubated under indicated conditions for 10 days without refreshing the 
supernatant. 
In nature, lysyl oxidase is used to cross-link components of the extracellular matrix. 
Lysyl oxidase oxidizes the amine side chain of lysine to an aldehyde, which can then 
either react with an amine to form a Schiff base, or it can undergo an aldol condensation 
with another aldehyde, both of which result in the formation of a covalent cross-link 
between two previously separate residues (Figure 3.2).5,6 Lysyl oxidase is also found in 
serum-supplemented cell culture media. 10 One way to determine if this oxidative cross-
linking was taking place in our system is to inhibit lysyl oxidase, thereby preventing 
oxidative cross-linking, while simultaneously monitoring G'. For these experiments, an 
irreversible inhibitor of LO was chosen: ~-aminopropionitrile ((3APN).ll K2(SL )6K2 was 
made into a gel using cell culture medium and FBS to which no inhibitor was added 
(control). Three additional gels were made utilizing medium and 10% FBS to which 
78 
different concentrations of (3APN were added as inhibitors and G' was monitored for 10 
days. As shown in Figure 4.4b, 50mM (3APN results in a 0' comparable to that of 
medium with no FBS. Lower concentrations of (3APN result in inhibition to a lesser 
degree. This strongly suggests that lysyl oxidase is the key component responsible for the 
change in rheological properties. 
If oxidative cross-linking is indeed taking place, this process should be reproducible 
by the exogenous addition of enzyme in the absence of serum or cells. Thus, experiments 
were repeated without any fetal bovine serum or cell culture medium of any kind. As 
lysyl oxidase is not commercially available, plasma amine oxidase (PAO), an enzyme 
with a similar mechanism of action, was used.12,13 Both lysyl oxidase and plasma amine 
oxidase fall into the same class of enzymes, the copper-containing amine oxidases 
(CuAOs). This class of enzyme is known to be involved in the development and 
maturation of the extracellular matrix and more specifically, collagen and elastin. 14 
Hydrogels ofK2(SL)6K2 were treated with PAO (but no serum) and the 0' monitored 
over 15 days. As was observed with serum treated gels, the 0' increased dramatically 
over time. As with serum treated gels, addition of (3APN, which also inhibits PAO, 
resulted in the same lack of increase in the storage modulus indicating that cross-linking 
did not take place (Figure 3.5). Rheology has historically been used to estimate the 
degree of cross-linking in polymer systems where 0 is directly proportional to the degree 
of cross-linking. The clear increase in 0' in the presence of active enzyme can be 
attributed to progressively higher degrees of cross-linking while the lack of increase in 
the presence of an enzyme inhibitor or in systems lacking the amino acid lysine indicates 
that no cross-linking is taking place. 14,15 
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Figure 3.5. Storage modulus (0') without PAO, with PAO and with PAO plus ~APN as 
an inhibitor. The values of 0' were chosen at an angular velocity of 0.5 rad/sec in the 
linear viscoelastic region. 
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Figure 3.6. AFM ofK2(SL)6K2 nanofibers a) before gelation, b) after gelation but before 
treatment with PAO, c) after four days of treatment with PAO. d) Average height of 
fibers as measured by AFM. 
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AFM ofK2(SL)6K2 shows small, discrete self-assembled fibers prior to addition of 
phosphate buffer (Figure 3.6a). In the presence of phosphate these small fibers undergo 
further self-assembly in which they are physically cross-linked by the presence of 
phosphate (Figure 3.6b). Treatment with PAO results in the covalent capture of the gel 
network (Figure 3.6c). The introduction of covalent bonds between individual peptides 
results in some forced aggregation of peptide fibers that appears as fiber thickening. The 
general fibrous nature of the gel network, however, is preserved after treatment with the 
enzyme suggesting that the nanostructure is relatively unchanged. However, an increase 
in fiber height is observed over time, from approximately 1.6 nm at time zero to 2.7 nm 
after seven days of treatment with PAO (Figure 3.6d). This suggests fiber bundling 
occurs during oxidative cross-linking. The general fibrous nature of the gel network, 
however, is preserved after treatment with the enzyme suggesting that the nanostructure 
is relatively unchanged. 
B. Conclusions 
The results of this study have two important consequences. First, nanofibers formed 
from multi domain peptides that contain lysine will be oxidatively cross-linked in 
standard mammalian cell culture conditions (supplemented with FBS) this can have a 
desirable impact on the handling of the hydrogel as it becomes more robust with time 
rather than less robust. Additionally, studies that attribute improvements in mechanical 
properties of hydro gels to the production of ECM should first be careful to rule out 
covalent cross-linking of the matrix used. This covalent cross-linking in standard cell 
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culture conditions is possible without added enzymes, as lysyl oxidase is found in serum-
supplemented media. Second, this study is a proof-of-principle that lysine oxidation 
using exogenous addition of plasma amine oxidase can be harnessed to cross-link self-
assembled nanofibers. Enzymatic cross-linking via aldehyde formation and subsequent 
condensation represents a mild and simple method for increasing the mechanical strength 
of peptide hydrogels in applications for which the robustness of the gel is essential. This 
method should be suitable for a broad array of peptide hydro gels containing a high 
density of lysine such as those currently under study by many different groupS.16-19 
c. Experimental 
Peptide Synthesis. Peptides were synthesized as previously described with the 
following changes: A Rink Amide MBHA low loading resin was used to generate a 
terminal amide. All amino acids and other reagents were dissolved in a mixture of 50% 
MDF (dimethylformamide) and 50% DMSO (dimethylsulfoxide). Amino acid coupling 
cycles were 60 min in length with the following proportions of reagents: 4 equivalents of 
amino acid, 4 equivalents of HATU (0- (7-azabenzotriazole-l-yl)-N,N,N,N'-
tetramethyluronium hexafluorophosphate), and 6 equivalents of diisopropylethylamine 
for each equivalent of reactive site on the solid support. Fmoc 
(flourenylmethoxycarbonyl) was removed with two 7 min treatments of 20% piperidine, 
2% DBU (l,8-diazabicyclo[5.4.0]-undec-7-ene), 39% DMF, and 39% DMSO by volume. 
Preparation of Gels. Gels of K2(SL)6K2 were prepared by dissolving lyophilized 
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powder in deionized water, followed by adjustment of the pH to approximately 7 by 
addition of NaOH. Deionized water was added to make a viscous solution with a 
concentration of 2% by weight. To this solution 2x PBS (phosphate buffered saline) was 
added in equal volume to make a final solution of peptide at 1 % by weight, pH 7.4. The 
solution was vortexed thoroughly to ensure full mixing. The resulting gel was centrifuged 
to eliminate bubbles. Gels of Ez(SL)6Ez were prepared by dissolving lyophilized powder 
in deionized water followed by adjustment of the pH to approximately 7. Deionized water 
was added to make a viscous solution with final concentration of 2% by weight. To this 
solution,4 mol equiv of aqueous MgCl2 was added in equal volume to make a final 
solution of peptide at 1% by weight. The solution was vortexed thoroughly to ensure full 
mixing. The resulting gel was centrifuged to eliminate bubbles. 
Time Course Oxidation. A total of 100 J.LL of MDP gel was pipetted into individual 
wells of a 96-well plate. To the top of these gels was added 200 /-LL of test solution. The 
test solution compositions included (1) PBS (phosphate buffered saline: 10 mM 
phosphate, 150 mM NaCl, pH 7.4), (2) medium (R-MEM, 50 /-Lg/mL L-ascorbic acid 2-
phosphate, 100 U/mL penicillin, and 100 /-Lg/ mL streptomycin), (3) 10% PBS in medium 
(R-MEM supplemented with 10% fetal bovine serum, 50 /-Lg/mL L-ascorbic acid 2-
phosphate, 100 U/mL penicillin, and 100 /-Lg/mL streptomycin), (4) 10% PBS in medium 
(as above) supplemented with 0.05, 5, or 50 mM APN as inhibitor, (5) 10% PBS in 
medium (as above) with SHED (mesenchymal stem cells from human exfoliated 
deciduous teeth) cells, and (6) 100% PBS. In addition, there were two conditions that 
contained no FBS or cell culture medium of any kind: (7) 3 nM plasma amine oxidase in 
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PBS and (8) 3 nM plasma amine oxidase in PBS supplemented with 50 mM j3APN as 
inhibitor. The plate was incubated at 37°C for the requisite amount of time. One-half of 
the supernatant was refreshed every second day. Gels were carefully transferred to the 
rheometer at the desired time point with a spatula, taking care not to damage the gel 
during handling. Gels were not pi petted because the shear-thinning induced by this 
method would produce a measurable decrease in the elastic modulus of the gel. 
Rheometry. A TA Instruments AR-G2 rheometer with a parallel plate geometry (8 
mm diameter and 250 IIDl gap) was used for all experiments. The gels were placed 
carefully in the headspace with a spatula, and the geometry was then lowered to the 
preset gap. Oscillatory strain sweeps were performed at 25°C at a fixed angular velocity 
of 0.5 rad/s. Oscillatory stress sweeps were performed using a fixed angular velocity of 
0.5 rad/s. Oscillatory frequency sweeps were performed using a fixed strain of 0.5%. 
Atomic Force Microscopy (AFM). A total of 8 J.1L of K2(SL)6K2 in PBS buffer at pH 
7.4 (with or without added PAO) were dropped onto freshly cleaved mica while spinning 
at medium speed on a Headway Research, Inc. photoresist spinner. The sample was 
rinsed with deionized water for 4-5 s and then spun for an additional 10 min. The sample 
was then placed in a desiccator until imaging. AFM images were collected in air as 
described previously. All AFM images were flattened using Nanoscope software and 
height profiles were generated from the flattened images. From these profiles, for each 
time point measured (0, 1,4, and 7 days treatment with PAO and without PAO) , 20 fiber 
heights were averaged and a standard deviation was generated. 
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Chapter 4: Multidomain Peptides as Drug Delivery Vehicles' 
Self-assembling peptide nanofiber hydrogels are a promising class of synthetic 
biomaterials that have been investigated for a wide variety of biomedical applications, 
including cell scaffolds l -6 and drug delivery agents.7-9 The powerful biomedical 
applications of peptide hydrogels derive from the ease with which new and diverse 
peptide sequences can be prepared, the nanostructure obtained through their self-
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assembly,1O the presentation of chemical information on their surface, and the rheological 
properties I 1-14 of the resulting hydrogel materials. Additionally, these self-assembling 
peptide nanofiber hydrogels can be designed to bind proteins, cells or to degrade in a 
predictable fashion with respect to time and location. 15, 16 Successful delivery of 
therapeutic molecules is dependent on being able to achieve controlled release of these 
molecules from the peptide hydrogel. Controlled release from peptide hydro gels has been 
demonstrated with small molecules,9, 17 and with proteins, for example growth factors. 15, 
IS, 19 Other hydrogel systems have also been demonstrated to deliver growth factors such 
as vascular endothelial growth factor (VEGF) to tissues?O It has also been shown that 
delivery ofPDGF by self-assembling nanofibers decreases infarct size and improves 
cardiac function after myocardial infarction.21 Likewise, tethering of insulin-like growth 
factor (IGF-l) to self- assembling peptide nanofibers increases survival of neonatal rat 
. This section is based on two publications: 
Yin Wang, Erica Bakota, Benny H. J. Chang, Mark Entman, Jeffrey D. Hartgerink, and 
Farhad R. Danesh. Peptide Nanofibers Preconditioned with Stem Cell Secretome Are 
Renoprotective. J Am. Soc. Nephrol., 2011, DOl: 10.16811ASN.201 0040403. 
Erica L. Bakota, Yin Wang, Farhad Danesh, and Jeffrey D. Hartgerink. Injectable 
Multidomain Peptide Nanofiber Hydrogel as a Delivery Agent for Stem Cell Secretome. 
Biomacromolecules, 2011, accepted for publication. 
cardiomyocytes after myocardial infarction?2 Peptide hydrogels have also been 
investigated as an injectable means of delivering stem cells.23 
A. Embryonic Stem Cells as Therapeutic Agents 
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Stem cells are known to have beneficial effects on tissues and are being widely 
investigated as potential therapies. Stem cells hold great promise for the kidney, and 
multiple studies have suggested that stem cells and specifically mesenchymal stem cells 
may contribute to the recovery of kidneys after acute kidney injury (AKI)?4-34 However, 
the mechanism by which stem cells are exerting beneficial effects on the kidney is 
unclear. The rate of stem cell engraftment in many cases appears too low to explain the 
significant renal improvement after acute kidney injury. Improvements in the clinical 
outcome may not necessarily result from direct contact of the diseased tissue with stem 
cells but rather from another mechanism instead. An alternative hypothesis has been 
recently advanced, suggesting that the beneficial effects of stem cells in the kidney may 
not depend on their capacity to reconstitute the denuded cells directly, but rather on their 
paracrine/endocrine ability to release cytokines, chemokines, and growth factors. 35-38 
Any material with the ability to harness this secretome would carry enormous 
therapeutic potential, and peptide materials are well-suited for this purpose. In fact, this 
concept has already been demonstrated with peptide-based materials, in which peptide 
amphiphile nanofibers were able to absorb and release paracrine factors derived from 
stem cells and release them in a therapeutic setting. 19 
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In the current study, we describe the development of a novel self-assembled peptide 
nanofiber-based preparation, which effectively delivers paracrine/endocrine factors 
secreted from mouse embryonic stem cells (ESCs) both in vitro and in vivo. We 
hypothesized that the use of nanofibers preconditioned with ESCs might enhance kidney 
tissue repair by providing an acellular delivery platform for bioactive molecules released 
from ESCs. We argue that this novel approach could harness the beneficial effects of 
stem cells in the repair and remodeling of damaged organs, while circumventing many 
limitations associated with the use of ESCs in vivo, including issues with limited cell 
engrafiment, cell viability, immune tolerance, and formation of teratomas. 
B. Self-Assembling Multidomain Peptide Nanofibers 
Although nanofibers can be prepared in a number of different ways, self-assembly an 
exceptionally powerful method because it affords excellent control over chemical 
composition, size in all dimensions, and the dynamic nature of the assembled fiber. 
Recently we introduced a new class of self-assembling peptide nanofibers called 
multi domain peptides (MDPs).lO Designed in this study is a new multidomain peptide, 
E2(SL)6E2GRGDS (Figure 4.1), which incorporates the negatively charged glutamic acid 
in the charged block and utilizes six pairs of alternating serine, leucine to create the 
amphiphilic central block. Additionally this peptide includes the well-known cell 
adhesion sequence RGD.39, 40 While nanofibers always form in water, gelation is 
triggered by a number of different methods that result in the neutralization or screening of 
the negative charges on the glutamic acid residues. A similar method of self-assembly has 
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been used in other similar peptide systems.41 While these salts are not required, they 
dramatically enhance the speed of gelation. In this study, MgCh is used due to its 
compatibility with cell culture conditions. 
a. 
b. 
Ion Induced 
Self-assembly 
Figure 4.1. Self-assembly of E2(SL)6E2GRGDS into nanofibers. (a) Chemical structure 
ofE2(SL)6E2GRGDS. (b) Scheme depicting assembly of the peptide dimer repeating unit, 
a "hydrophobic sandwich" that assembles into a nanofiber. 
E2(SL)6E2GRGDS was prepared via solid phase peptide synthesis and the product 
was verified using MALDI-TOF mass spectrometry. After dialysis against deionized 
water, this peptide was characterized using circular dichroism (CD) and infrared (lR) 
spectroscopy. CD spectra indicate a ~-sheet secondary structure, with minima at 217 nm 
and maxima at 197 nm (Figure 4.2a). Gelation with Mg2+ reinforced this signal, inducing 
an increase in the maximum at 197 nm with a simultaneous decrease at 217 nm. The IR 
spectra indicate the presence of an anti-parallel ~-sheet structure with an amide III band at 
1616 cm-1 and amide L at 1690 cm-1 (Figure 4.2b). IR spectra prior to gelation show 
identical features to the hydrogel (data not shown). 
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Figure 4.2. a) Circular dichroism (CD) measurements of E2(SL)6E2GRGDS before and 
after gelation with Mg2+. b) Infrared (lR) spectroscopy of E2(SL)6E2GRGDS after 
gelation. 
Figure 4.3. Atomic force microscopy (AFM) ofE2(SL)6E2GRGDS a) before gelation and 
b) after gelation with Mg2+. White lines in left images indicate the axis of height profiles 
shown at right. Red triangles denote the points between which the height differential was 
measured. Images are 3 x 3 !J.m. 
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Atomic force microscopy (AFM, Figure 4.3) and vitreous ice cryo-transmission 
electron microscopy (TEM, Figure 4.4a and 4.4b) confirmed the presence of an extended 
nanofiber network. These peptide nanofibers result in the formation of a hydrogel in the 
presence of cell culture media that has been supplemented with Mg2+ (Figure 4.4c). It has 
been well-established that ion screening of charged amino acids plays a huge role in the 
formation of self-assembled peptide nanofibers.41 This hydrogel can be visualized by 
critical point-drying, followed by SEM, which reveals a sponge-like internal structure 
(Figure 4.4d). 
Figure 4.4. a & b) Vitreous ice cryo-TEM ofE2(SL)6E2GRGDS nanofibers, c) a hydrogel 
of nanofibers formed in cell culture medium, d) SEM of the resulting peptide hydrogel. 
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C. In vitro studies' 
Previous multidomain peptides have demonstrated cytocompatibility,16 making them 
appealing for use in biomedical applications such as a drug delivery vehicle in vitro and 
in vivo. The ability of the E2(SL)6E2GRGDS hydrogel to deliver cytokines to endothelial 
cells in vitro was examined to determine if preconditioned peptide hydrogels could 
reverse artificially induced cell injury. 
1. Effect of Preconditioned Nanofibers on LPS-Induced Cell Hyperpermeability 
Lipopolysaccharide (LPS) is a toxin produced by bacteria that is known to have 
detrimental effects on tissues. The low-dose intraperitoneal (ip) injection of LPS is an 
established model of endotoxemia as described in several recent studies.42-45 The 
underlying molecular mechanisms leading to LPS-induced kidney injury are complex and 
incompletely understood. However, it is clear that endothelial cell hyperpermeability and 
cell apoptosis are key mechanisms involved in the pathogenesis of LPS-induced 
disease.45-48 Because growth factors and cytokines are also known to affect cell 
permeability and apoptosis, it was thought that peptide hydro gels loaded with these 
compounds may have an effect of diseased or injured cells. Thus, the effect of 
preconditioned nanofibers on these key features of LPS-induced AKl was assessed in a 
laboratory model. 
. Hyperpermeability and apoptosis experiments were performed by Yin Wang, Baylor 
College of Medicine. 
We initially examined the effect of preconditioned nanofibers on LPS-induced 
endothelial cell hyperpermeability under in vitro conditions by determining the 
permeability of 125I_BSA across confluent endothelial cell monolayers.49 Our initial 
strategy was to employ two experimental preparations of nanofibers: (1) encapsulated 
nanofibers in which ESCs were embedded in designer peptide nanofibers for I hour 
94 
(Figure 4.5a) or (2) preconditioned nanofibers that were prepared by exposing nanofibers 
to secretome from ESCs in a transwell coculture system for 24 hours (Figure 4.5b). To 
investigate the effect of preconditioned nanofibers on endothelial cell permeability, we 
employed a transwell system containing confluent kidney microvascular endothelial cells 
in the upper chamber separated from preconditioned nanofibers (100 !-tL) in the lower 
chamber by a cell-impermeable membrane (Figure 4.5b). 
b. 
24 hours 
Nanofibers Nanofibers 
Figure 4.5. a) Scanning electron micrograph of mouse ESCs encapsulated in self-
assembled peptide nanofibers. b) Schematic representation of the two-compartment 
transwell co culture system for preparation of preconditioned nanofibers. 
Figure 4.6 depicts the effect ofLPS on endothelial cell monolayer integrity. Upon 
addition of LPS (100 ng/ml) in the upper chamber, we detected a significant increase in 
endothelial cell permeability. In contrast, cocultures of endothelial cells with either ESCs 
alone, encapsulated nanofibers, or preconditioned nanofibers prevented LPS-induced 
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endothelial cell hyperpermeability. However, nonconditioned nanofibers had no effect on 
LPS-induced cell permeability. 
To test whether the modulatory effect of preconditioned nanofibers on cell 
permeability is restricted to LPS, we assessed the effect of preconditioned nanofibers on 
vascular endothelial growth factor- induced (VEGF -induced) cell permeability. As shown 
in Figure 5.6b, preconditioned nanofibers, encapsulated nanofibers, and ESCs alone also 
prevented VEGF-induced (50 ng/ml VEGF) endothelial cell hyperpermeability. This 
shows that the modulatory effect of preconditioned nanofibers on endothelial cell 
permeability is not restricted to LPS, and potentially involves a critical downstream target 
of cell permeability pathway. Together, these results strongly suggest that 
preconditioning of nanofibers allows delivery of bioactive molecules from ESCs to 
targeted cells in vitro. 
a. 
* 
* p<O.OOl versus Control 
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b. * p<O.OOl versus Control 
T p<o.OOl versus VEGF 
Figure 4.6. a) Quantification of kidney microvascular endothelial cell permeability 
exposed to LPS (100 ng/ml) for 4 hours. Bar graphs summarize results as mean ±SEM (n 
= 3 separate experiments in triplicate). b) Quantification of kidney microvascular 
endothelial cell permeability exposed to VEGF (50 ng/ml) for 6 hours (n = 3 separate 
experiments in triplicate). Figure by Yin Wang. 
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2. Preconditioned Nanofibers Decrease LPS-Induced Apoptosis 
Having found that preconditioned nanofibers protect against LPS-induced cell 
permeability, we assessed their effect on LPS-induced cell apoptosis in cell culture. LPS 
is well known for its toxicity and is often used to simulate kidney injury. We found that 
LPS treatment (100 ng/mL) significantly increased cell apoptosis in tubular cells and 
podocytes. In contrast, effect of LPS on cell apoptosis was prevented in the presence of 
ESCs alone, encapsulated nanofibers, or preconditioned nanofibers. 
3. Effect of Preconditioned Nanofibers on Glucose-Induced Cell Hyperpermeability 
We also investgated the ability of preconditioned multi domain peptide nanofiber 
hydro gels to ameliorate a cell culture model for diabetes induced kidney damage. 
Glomerular Epithelial Cells (GECs) in the kidney form a selectively permeable 
membrane, which becomes increasingly leaky to proteins at high concentrations of 
glucose. High glucose conditions, while not typically experienced by healthy individuals, 
may occur as a result of diabetes. This is a primary mechanism by which diabetes impairs 
kidney function. It is possible to track the permeability of GECs to protein by measuring 
the throughput of the protein bovine serum albumin (BSA). After the preconditioning 
step, the peptide hydrogel is placed in a culture of Glomerular Epithelial Cells (GECs) 
and the permeability of I 125 BSA is monitored over time under both low and high glucose 
conditions. As a control, hydrogels preconditioned by the ESC fibroblast feeder layer 
were used (pre-MEM-NF). In this control, only the fibroblast layer was used; no ESCs 
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were present. As expected, GECs were found to have increased permeability in the 
presence of high glucose levels, which is observed by the 50% increase in clearance rate 
Ofl125 BSA (Figure 4.7). It was found that in the presence of ESC secretome-Ioaded 
MDP hydrogels (pre-hES-NF), the permeability of GECs was reduced to approximately 
the level of cells treated with low glucose. In contrast, MDP hydrogels preconditioned 
with the mouse fibroblast feeder layer had no significant effect on BSA clearance. 
* 
r----l 
** 
Figure 4.7. Relative permeability rate of albumin of glomerular epithelial cells incubated 
in low (LG) and high glucose (HG) conditions. Cells in high glucose conditions were also 
incubated with MDP hydrogel that had been preconditioned either with human 
embryonic stem cells (pre-hES-NF) or with the mouse fibrobloast feeder layer (pre-MEF-
NF). Data are shown as mean ± SEM. Statistical significance was assessed by performing 
analysis of variance (ANOV A) followed by the Tukey-Kramer post-hoc analysis for 
multiple comparisons using an alpha value of 0.05. * P<0.05, **P<O.Ol. 
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D. In vivo studies 
1. Rheological Properties of E2(SL)6E2GRGDS Hydrogels 
Once the utility ofE2(SL)6E2GRGDS had been established in vitro, its suitability as 
an in vivo material was investigated. Materials designed for use in a clinical setting are 
subjected to very different conditions from those used in a laboratory setting. For 
example, a peptide hydrogel might undergo negligible stress or strain while in a cell 
culture well plate but may experience considerable deformation when injected through a 
syringe and needle. Thus it was necessary to examine the hydrogel's mechanical 
properties to determine its suitability for clinical use. 
A peptide hydrogel designed for drug delivery in a clinical setting should have 
several useful mechanical properties: stability of the hydrogel over time, the ability to 
undergo shear thinning and subsequently recover, and the ability of the hydrogel to be 
loaded with therapeutics and subsequently release them in a targeted environment. The 
multidomain peptide E2(SL)6E2GRGDS satisfies all of these conditions. The stability of 
this peptide was first tested on a controlled-stress rheometer by performing a time sweep, 
which showed that the peptide hydrogel was stable over the time frame necessary to 
complete rheological tests. The peptide hydrogel was also measured over the course of 
several weeks, and no significant changes were observed. Thus, incubation time does not 
affect the rheological properties of the hydrogel. The rigidity of this peptide was tested on 
a controlled-stress rheometer by performing a strain sweep (Figure 4.8a), which shows a 
storage modulus of approximately 480 Pa. One potential limitation of peptide hydrogels 
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is that their fragility may make delivery of the hydrogel in a biological setting 
impractical. On the other hand, excessive robustness without shear thinning may preclude 
injection of a hydrogel altogether. Peptide materials have been shown to avoid both of 
these issues, making them ideal drug delivery systems.9 E2(SL)6E2GRGDS specifically 
demonstrates an ability to both undergo shear thinning and recover rapidly after needle 
shear, thus allowing inj ection of the peptide hydrogel directly into the site of interest 
without permanent loss of hydrogel properties. Needle shear was simulated by applying 
100% strain for 1 minute. This was immediately followed by monitoring the recovery of 
the elastic modulus, G', over time. It was found that this peptide recovers over 75% of its 
elastic modulus immediately (within 13 seconds, the smallest time interval measured 
during rheometry) and 100% of its elastic modulus within 10 minutes of removal of the 
shear (Figure 4.8b). 
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Figure 4.8. (a) Strain sweep performed after gelation with Mg2+. (b) Time sweep 
performed on E2(SL)6E2GRGDS gel, with shear being applied at T = -1 and removed at 
t=O. 
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Figure 4.9. Time sweeps performed on the peptide hydrogel before needle shear (red) 
and after needle shear (blue) using a syringe fitted with a 21 G needle. 
However, it is important to note that simulated needle shear may not be identical to 
actual needle shear due to differences in geometry between the rheometer and a syringe, 
so shear-thinning tests were then performed using a syringe and 21 G needle. In these 
experiments, the peptide was placed carefully on the rheometer plate (taking care to 
disturb the gel as little as possible) and a time sweep was performed to measure the 
elastic modulus of the gel over 15 minutes. Then the peptide was removed, loaded with a 
spatula into a syringe fitted with a 21 G needle, and the gel was squirted through the 
needle onto the rheometer plate, where the elastic modulus of the gel was monitored over 
another IS-minute interval (Figure 4.9). After shearing through the syringe and needle, it 
was evident that the G' of the gel was not affected. Thus, gels of this type are well-suited 
for delivery via injection. 14 
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2. MRI Tracking Experiments 
The peptide hydrogel's ability to be used as a drug delivery matrix was then 
examined. First, a tracking experiment was performed to ascertain the fate of the 
hydrogel upon injection. Gadolinium is frequently used to enhance contrast in magnetic 
resonance imaging (MRI), and it is estimated that at least 30% ofMRIs performed today 
utilize chelated gadolinium for this purpose.50 A Gd3+ labeled version (see Supporting 
Information) of the hydrogel was prepared and carefully injected into the abdominal 
cavity of a mouse, and the localization of the hydrogel was monitored by magnetic 
resonance imaging (MRI). After injection, scans were acquired at 30 minutes, 1.5 hours, 
3 hours, 6 hours, 12 hours and 24 hours. All experiments were repeated at least in 
triplicate.51-54 Figure 4.10 shows that the labeled hydrogel can be visualized at 24 hours 
post-injection, demonstrating that a peptide hydrogel could be delivered to a site of 
interest without immediate dissolution into the surrounding body tissues. This lack of 
dissolution is related to the ability of this hydrogel to recover after shearing through the 
syringe and needle. The rapid recovery of the elastic modulus after needle shear allows 
the gel to regain its nanostructure faster than the time that is required to flow into the 
surrounding body tissues. Thus, the E2(SL)6E2GRGDS hydrogel is ideally suited for 
injection in vivo, as it maintains structural integrity immediately following injection. 
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Figure 4.10. Left: Nanofibrous MDP hydrogel undergoes shear thinning and shear 
recovery allowing simple injection in vivo. Right: MRI tracking of gadolinium-labeled 
nanofibers 24 hours after injection into the abdominal cavity of mouse. The red arrow 
indicates the position of the localized hydrogel. 
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Figure 4.11. Magnetic resonance imaging (MRI) of localized hydrogel at 0, 3, 6, and 
24 hours post-injection. At 24 hours concentrated areas of hydrogel can still be observed. 
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3. Effect of Preconditioned Nanofibers on the LPS Model of AKI in Mice' 
The experiments described above provide strong evidence for a protective effect of 
preconditioned nanofibers in vitro. Furthermore, rheological studies indicated that the 
E2(SL)6E2GRGDS hydrogel behaves ideally for use as an injectable material. However, 
it was unclear whether preconditioned nanofibers would actually exhibit the expected 
renoprotective effects in vivo. To address this question, we examined the effect of 
preconditioned nanofibers on the LPS model of AKI in mice.42 A single intraperitoneal 
injection ofLPS (10 I-lg/g body weight) produced a significant increase in albuminuria 
and caused an abrupt rise in serum BUN and creatinine (Figure 4.12, a-c). Serum BUN 
and creatinine are considered the gold standard for biomarkers of kidney function. 
Increased serum BUN and creatinine are indicative of a disease state. In contrast, 
intraperitoneal treatment with preconditioned nanofibers (200 I-lL) 1 hour after LPS 
injection markedly prevented LPS-induced proteinuria (Figure 4.12, a and b). Likewise, 
serum BUN and creatinine levels were significantly reduced in mice administered 
preconditioned nanofibers (Figure 4.12c). This indicates that preconditioned nanofibers 
improved kidney function in treated mice . 
. Experiments on AKI in mice were performed by Yin Wang, Baylor College of 
Medicine. 
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Figure 4.12. Mice treated with preconditioned nanofibers are protected from LPS-
induced kidney injury. A) Quantitative analysis of albumin! creatinine ratio (n = 6 to 11 
per group). B) Representative SDS-PAGE analysis of the urine. C) Quantitative analysis 
of serum creatinine and BUN (n = 6 to 11 per group). Figure by Yin Wang. 
Histologic analyses of kidneys obtained from animals allocated to preconditioned 
nanofibers with ESCs also showed a remarkable improvement (Figure 4.13a). Tubular 
epithelial cells were swollen and vacuolated 24 hours after LPS administration, but 
significantly improved in mice that received treatment with preconditioned nanofibers. 
We also assessed the effect of preconditioned nanofibers on podocyte injury based on 
two recent studies.42, 43 As depicted in Figure 4.13b, preconditioned nanofibers 
ameliorated LPS-induced podocyte effacement observed in some glomerular areas. 
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Similarly, although administration of LPS caused a significant increase in cell apoptosis 
in peritubular, vascular, tubular, and podocytes, the use of preconditioned nanofibers 
markedly mitigated the number of apoptotic cells in the kidneys (Figure 4.13, c and d). 
Furthermore, we also performed caspase-3 activation assays. LPS caused a significant 
increase in caspase-3 activation (Figure 4. 13e). This increase was prevented in mice 
treated with preconditioned nanofibers. Together, these results suggest that the 
preconditioned nanofibers protect against LPS-induced apoptosis in the kidney in vivo. 
Next, we examined the effect of preconditioned nanofibers on the ischemia-reperfusion 
(I-R) model of kidney injury. As shown in Figure 4.13, fand g, in comparison with sham 
animals, mice that were subjected to I-R injury and were allocated to nonpreconditioned 
nanofibers showed a significant elevation of serum creatinine and BUN at 24 hours. 
However, mice that received preconditioned nanofibers intraperitoneally exhibited a 
marked improvement in serum creatinine (P < 0.05) and BUN (P < 0.05). Taken together, 
these findings suggest that preconditioned nanofibers protect against kidney injury in 
different models of AKI. 
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Figure 4.13. A) Renal histology was assessed by H&E staining 24 hours after LPS 
administration. Tubular injury is indicated by vacuolization of tubular epithelial cells 
(arrows) (original magnification: 400x). B) Representative TEM images of the 
glomerular capillary wall. LPS-treated mice exhibit effacement of foot processes, 
whereas mice treated with preconditioned nanofibers show a significant improvement in 
podocytes (original magnification: 15,OOOx). C) Apoptosis was quantified by TUNEL 
staining of formalin-fixed kidney tissue. After LPS administration, apoptotic nuclei were 
identified in glomeruli, tubules, and arterioles (arrows) (Magnification: 400x 
counterstained with hematoxylin). Apoptosis was quantified as described previously.55 D) 
Results of apoptosis obtained from five different mice in each group. HPF, high power 
field. E) Results of caspase-3 activation obtained from kidney cortex lysates (n = 5 mice 
per group). F) Quantitative analysis of serum creatinine and BUN G) (n = 6 mice/group) 
in the I-R model of AKI. Data are shown as means ± SEM. Figure by Yin Wang. 
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E. Analysis of Secretory Proteome from Preconditioned N anofibers 
ESCs have been shown to secrete a broad spectrum of cytokines, chemokines, and 
growth factors. 56 We performed a semi qualitative cytokine antibody array analysis to 
assess the secretome from preconditioned nanofibers. To this end, preconditioned 
nanofibers were transferred to a solution of PBS, and the PBS solution was then removed 
and replaced periodically to assess the release of secreted proteins. As a control, 
nonconditioned nanofibers were also analyzed. Overall, a total of 36 secreted proteins 
were differentially increased in conditioned PBS (Figure 4.14a). This suggests that 
preconditioned nanofibers can retain and release paracrine/endocrine factors from ESCs. 
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Figure 4.14. A) Cytokine array profiling was performed on nonconditioned and 
preconditioned nanofibers using a biotin-labeled cytokine protein array system. B) 
Knockdown of three secreted proteins (follistatin, adiponectin, and SLPI) showing the 
reduction at the mRNA levels. C) Quantification of albumin/creatinine ratio in mice 
treated with preconditioned nanofibers after simultaneous triple knockdown. D) 
Immunoblot of Rho kinase activation from kidney lysates. Figure by Yin Wang. 
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To dissect the contribution of differentially expressed secreted proteins in the 
renoprotective effects of preconditioned nanofibers, we targeted proteins that were 
previously reported to play critical roles in the LPS model of organ injury. A survey of 
the literature prompted us to target follistatin, adiponectin, and secretory leukoprotease 
inhibitor (SLPI) as our initial targets. 57-59 Because we expected that the effects of 
preconditioned nanofibers might stem from multiple secreted proteins, in addition to 
designing siRNA oligos directed against the individual genes, we also used a 
combinatorial siRNA strategy for their simultaneous knockdown. To this end, before 
preconditioning of nanofibers, ESCs were transfected with siRNAs for individual or 
multiple genes simultaneously. Nanofibers were then preconditioned as described 
previously. We found that triple simultaneous knockdown offollistatin, adiponectin, and 
SLPI in ESCs prevented the renoprotective effect of preconditioned nanofibers in vivo 
(Figure 4.14, b and c). With use ofa combinatorial knockdown of these three genes, 
strong Rho kinase activation also remained unchanged in the kidneys of mice treated with 
LPS even in the presence of preconditioned nanofibers (Figure 4.14d). This suggests a 
critical role for follistatin, adiponectin, and SLPI as well as for Rho kinase activation as 
the underlying molecular mechanism by which preconditioned nanofibers exert their 
renoprotective effect. Interestingly, individual knockdown of these genes failed to 
prevent the effect of preconditioned nanofibers on Rho kinase activation. We also 
evaluated the effect of conditioned medium (ESC-CM) on our experimental model of 
AKI. Mice were injected intraperitoneally with conditioned medium (200 I-tL per mouse) 
1 hour after injection ofLPS. Interestingly, no significant benefit was observed with 
ESC-CM on albuminuria. This suggests that our designer nanofiber facilitates the uptake 
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of proteins from secretome, a feature not surprising considering that nanofibers exhibit 
extremely high surface area-to-volume ratio.60 
Finally, we asked whether the use of preconditioned nanofibers would protect the 
secretome from proteolysis. We characterized the effect of preconditioned nanofiber on 
the degradation of osteopontin (OPN), a secreted glycoprotein, which was significantly 
upregulated in the secretome. We used purified recombinant OPN and active matrix 
metalloproteinase 3 (MMP3) to perform a cleavage assay. In the presence ofMMP3, 
OPN was cleaved to generate two additional fragments (40 and 32 kD). However, in the 
presence of preconditioned nanofibers, the pattern of cleavage of OPN was very similar 
to the control sample with the absence of low molecular weight bands, supporting the 
notion that preconditioned nanofibers provide a protease resistant environment. 
F. Conclusions 
In conclusion, we have shown that the multi domain peptide hydrogel self-assembled 
from E2(SL)6E2GRGDS is a suitable biomaterial for ESC secretome delivery. In the 
laboratory, drug loading and delivery has demonstrated by preconditioning the hydrogel 
in the presence of ESC and using these cell-free constructs to repair populations of cells 
that have been damaged either through LPS-induced injury or high glucose conditions. In 
both models of kidney disease, the peptide hydrogel was able to alleviate the increased 
permeability associated with the renal disease state. These results were echoed in vivo, as 
the preconditioned E2(SL)6E2GRGDS hydrogel was able to ameliorate high protein 
throughput in the urine that was associated with LPS-induced kidney injury. These 
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peptide nanofiber hydro gels exhibit clear cytoprotective properties. Our results also 
identifY follistatin, adiponectin, and SLPI as the key peptides in the therapeutic effects of 
preconditioned nanofibers. 
In addition to encouraging in vitro results, E2(SL)6E2GRGDS is an ideal injectable 
material. It forms a stable, nanofibrous hydrogel in the presence of Mg2+ and undergoes 
rapid shear thinning and recovery, allowing it to be easily delivered by syringe. Labeling 
with gadolinum via a covalently attached chelate illustrates the localization of the ~-sheet 
nanofiber network after injection in vivo. This phenomenon allowed directed and 
localized therapy in mice being treated for acute kidney injury. 
On the basis of these findings, we propose that preconditioned nanofibers serve as a 
novel acellular delivery platform for a broad spectrum of stem cells applications whereby 
beneficial effects of stem cells are preserved, whereas many limitations of stem cell 
therapy are circumvented. Coupling of peptide nanofibers with ESCs presents several 
advantages: (1) it provides an acellular platform for delivery of secretome from stem 
cells; (2) it offers an opportunity for a wider preclinical and clinical use of ESCs after 
organ injury because it circumvents the potential formation of teratomas; (3) by 
modifYing the designer peptide motifs, it is possible to pursue a more targeted therapy; 
(4) it may extend the biologic activity of cytokines and chemokines secreted from ESCs; 
(5) it can be used to dissect the paracrine/endocrine effects of stem cells on gene 
expression or cell-signaling processes; and (6) peptide nanofibers can break down into 
natural amino acids, which are nontoxic. Thus, peptide nanofibers may be useful as a bio-
reabsorbable source of delivery of secretome for kidney repair. A main advantage of 
using preconditioned nanofibers, which can potentially explain the lack of tissue pro-
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tective effects with ESC-CM, is the extremely high surface area-to-volume ratio of 
nanofibers that could facilitate the uptake and release of proteins delivered by the 
nanofibers.6o The combined topographical and biochemical signaling from peptide 
nanofibers may also playa role in enhancing biologic activities of paracrine/endocrine 
factors secreted from ESCs. 
In summary, we describe the demonstration of peptide nanofiber hydrogel as a novel 
platform for delivery of secretome released from stem cells. Our findings illustrate the 
utility of preconditioned nanofibers in developing alternatives to conventional stem cell 
therapy for a diverse set of diseases, including those involving kidney injuries. 
G. Experimental 
Peptide synthesis. All peptides were prepared by traditional solid phase peptide 
synthesis as described previously. A Rink Amide MBHA low loading resin (0.34-0.38 
mmollg) was used to ensure higher peptide yields. 
Peptide Gelation. A 1 wt% solution ofE2(SL)6E2GRGDS was prepared by dissolving 
the lyophilized powder in deionized water which was subsequently adjusted with NaOH 
to pH 7. While the peptide adopts a p-sheet structure in the absence of additional salts, 
the addition of MgCh enhances nanofiber formation and results in the formation of a gel. 
Mg2+ to peptide ratios of2:1 to 8:1 were investigated, and it was determined that the 4:1 
ratio imparted the optimal rheological properties to the peptide hydrogel. MgCh (1 M) at 
pH 7 was added so that the final ratio of Mg2+ to peptide was 4: 1 (1 % peptide by weight 
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= 4.45 mM, thus Mg2+ is 17.8 mM). The vial was capped, shaken briefly, and sonicated 
to obtain a uniform gel, which formed within seconds of mixing. Peptide preparations 
described as un-gelled are prepared as above but without addition of MgCh. 
Circular Dichroism Spectroscopy. CD spectra were recorded using a Jasco-810 
spectropolarimeter. For non-gelled peptides, samples at 1 wt% and pH 7 (adjusted with 
NaOH when necessary) were placed in a quartz cuvette with a path length of 0.001 cm. 
For samples gelled with Mg2+, the resulting 1 wt% gel at pH 7 was carefully pipetted into 
a 0.001 cm path length quartz cuvette, making sure to avoid bubble formation. Spectra 
were recorded at room temperature from 250 to 180 nm, with a 0.2 nm data pitch and a 
scan rate of 50 nrnImin. Milidegrees of rotation were converted to molar residual 
ellipticity (MRE). 
Attenuated Total Reflectance Infrared Spectroscopy (ATR-IR). 5 ilL of 1 wt% 
E2(SL)6E2GRGDS gel (gelled by the addition of Mg2+, as described above) at pH 7 were 
pipetted onto a "Golden Gate" diamond window and dried under nitrogen until a thin film 
of peptide was achieved. IR spectra (32 accumulations) were taken using a Jasco FTIIR-
660 spectrometer. 
Atomic Force Microscopy. 1 wt% peptide solutions at pH 7 (both gelled and un-
gelled) were diluted to a concentration of 0.01-0.05 wt% with ultra pure water. Samples 
were prepared as described in previous chapters. AFM images were collected as 
described previously. Gelled and un-gelled samples were prepared and imaged 
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separately. Data were collected in height and amplitude channels. Height profiles were 
measured using Nanoscope software. 
Vitreous Ice Cryo-Transmission Electron Microscopy (cryo-TEM) of Peptide Gels. 
Vitreous ice cryo-TEM samples were prepared using a controlled environment 
vitrification system (Vitro bot, FBI). 2.6 ~l of 2 wt% peptide gel were pipetted onto a 
holey carbon grid (Quantifoil Rl.2/1.3) and blotted with filter paper (Ted Pella, Inc.) for 
1 second. The sample then was quickly plunged into liquid ethane. The sample was 
transferred from liquid ethane to liquid nitrogen for storage. The sample was imaged as 
described previously. 
Scanning Electron Microscopy (SEM) of Nanofibers. 1 00 ~L aliquots of each gel 
were prepared and placed in a 24 well plate. Gels were dehydrated in a series 
ethanol/water solutions progressing from 30% ethanol to 100% ethanol over the course of 
24 hours. The dehydrated gels were critical point dried using an Electron Microscopy 
Sciences EMS 850 critical point drier. They were then affixed to SEM pucks using 
conductive carbon tape. The pucks were sputter coated with 10-15 nm gold using a CRC-
150 sputter coater and imaged using an FBI Quanta 400 ESEM at 20.00 kV. 
Scanning Electron Microscopy (SEM) of Embedded Cells. Cells were fixed with 3% 
glutaraldehyde plus 2% paraformaldehyde and 7.5% sucrose in 0.1 M cacodylate, 
postfixed with 1 % cacodylate buffered osmium tetroxide plus 7.5% sucrose, dehydrated 
with graded series ofhexamethyldisilazane-ethanol (HMDS-ethanol) series and air-dried 
overnight. Samples were examined with a JSM-5910 scanning electron microscope 
(JEOL USA, Peabody, MA) at an accelerating voltage of 5 kV. 
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Cell Culture. Conditionally immortalized renal microvascular endothelial cells were 
kindly provided by Dr. Robert Langley (University of Texas, M.D. Anderson Cancer 
Center)61. Conditionally immortalized mouse renal podocytes were provided by Dr. Peter 
Mundel (University of Miami).62,63 Mouse embryonic stem cell line (ESC-D3) was 
obtained from the Center for Stem Cell and Regenerative Medicine (Baylor College of 
Medicine) and derived from 129/Sv+l+ mouse as described previously and according to 
previously reported methods.64 HK2 cells (ATTC, Manassas, VA) were grown in 
complete keratinocyte serum-free media. Mouse embryonic fibroblasts (MEF) were 
obtained from 13-day-old CF-1 mouse embryos (Charles River) and according to 
previously reported methods.65 Cells were released by trypsinlEDTA digestion for 30 
minutes and harvested in 75-cm2 culture flasks at a density of 3 x 105 per mL in MEM-a 
supplemented with 10% FBS (Life Technologies, USA). Subcultures were prepared after 
the cells reached a confluence of >90% in the same medium. 
Preparation of Preconditioned Nanofibers and Conditioned Media. Preconditioning 
ofnanofibers was performed by exposing nanofibers (100 f,tL) to ESCs (2 X 105 cells) for 
24 hours in 24-well inserts (O.4-f,tm pore size) of a two-compartment transwell coculture 
system (BD Biocoat, MA) in which nanofibers were placed in the lower com- partment, 
whereas ESCs were seeded in the upper compartment in the presence of serum-free 
medium (knockout DMEM).66, 67 After 24 hours of conditioning, ESCs were removed 
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and media replaced. To prepare for encapsulated nanofibers, 2 x 105 ESCs were mixed 
with 100 IA-L ofnanofibers for 1 hour. Conditioned media from ESCs (ESC- CM) was 
prepared with 2 x 105 ESCs incubated in the presence of serum-free knockout DMEM for 
24 hours in an incubator at 37°C with 5% CO2 in 95% air. The ESC-CM was then 
collected and concentrated by ultrafiltration using centrifugal filters with a 3-kD 
molecular weight cut-off (Ami con Ultra-PL 3; Millipore, Bedford, MA). 
LPS (Escherichia coli 0111 :B4). LPS was obtained from List Laboratories 
(Campbell, CA). Antifibrin antibody was purchased from Nordic Immunological 
Laboratories (Tilburg, The Netherlands). Polyc1onal anti-phospho myosin phosphatase 
targeting subunit 1 (MYPT-1) (T853) antibody, recombinant MYPT-1, and recombinant 
Rho kinase 2 protein were from Upstate Biotechnology (Lake Placid, NY). Goat 
polyclonal antiosteopontin (OPN) antibody was from Abcam (Cambridge, MA), and anti-
OPN rabbit polyc1onal antibodies were obtained from Alexis Biochemicals (San Diego) 
and Rockland Immunochemicals (Gilbertsville, PA). Recombinant rat VEGF-A164 and 
human recombinant osteopontin (huOPN) were acquired from R&D Systems 
(Minneapolis). The catalytic domain of the matrix metalloproteinase (MMP)-3 was 
obtained from Alexis Biochemicals (San Diego). Cell culture media and supplies were 
from Invitrogen (Carlsbad, CA). 
Rheometry. Rheological measurements were taken using a TA Instruments AR-G2 
rheometer. Approximately 20 IA-L of peptide solution were placed within a preset gap of 
250 IA-m on an 8 mm steel parallel plate geometry. A frequency sweep was performed at 
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25°C and a frequency of 1 rad/sec was found to be in the linear viscoelastic region 
(L VR). This value was used to perform a strain sweep at 25°C and 1 rad/sec. Time 
sweep tests were performed at 25°C to determine the initial stability of the hydrogel as 
well as the recovery ability after shear. No breakdown of the gel was detected during time 
sweep measurements. In shear and recovery tests, the sample was pre-sheared to 100% 
strain for 1 minute and then a time sweep was performed at a frequency of 1 radian/sec 
and 0.5% strain for 20 minutes. To ensure that the sample only underwent shear rather 
than slipping, the phase angle was kept below 90°. 
Gadolinium Labeling of Peptides. The protocol for gadolinium labeling was obtained 
from BioPal (BioPAL, Inc. Worcester, MA) and followed as written. Dry peptide was 
dissolved in 0.2 M carbonate buffer at pH 8 and set aside. Separately, 393 jJL of a 
solution of 1 M sodium acetate and 1 M NaOH were added to a 2 mL vial containing - 5 
mg proprietary chelate. 7 jJL of 1 M GdCh were then added to this solution, which was 
then capped and vortexed until all solids were dissolved. This solution was allowed to sit 
for 5 minutes, and then 3 equivalents of the Gd-chelate solution were added to the peptide 
solution. This solution was allowed to mix for 2 hours and was then purified by dialysis 
and subsequently lyophilized. The powder was reconstituted in phosphate-buffered saline 
and gelled by addition of Mg2+. 
Animal Setup for MRI Tracking. Female C57BLKS/J mice weighing 20-30 g were 
purchased from Jackson Lab. Mice were intubated and inhalational isoflurane (1.5-2%) 
was administered through the endotracheal tube. Pulse and oxygenation, temperature, 
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end-tidal C02 and respiratory rate were monitored during the entire MRI scan period. The 
mice were kept warm using a water heater. 200-300 f.A.L Gd-conjugated nanofibers were 
injected into the mice using a 1 mL syringe with a 23 gauge needle. 
MRI Tracking Experiment. Experiments were performed using a vertical bore 11.7 T 
Bruker Avance imaging spectrometer with a microimaging gradient insert and 30 mm 
birdcage RF coil (Bruker Instruments, Billerica, MA). Tl-weighted images were acquired 
using a 2D gradient echo sequence. The sequence parameters were: TR = 500ms and TE 
= 8.233ms, Field of View (FOV) 40 x 40mm, Matrix size 256 x 256, 30 consecutive 
coronal slice with slice thickness 0.5 mm. 4 averages were taken, with a scan time of 6 
minutes, 24 seconds. To minimize motion artifacts, data acquisition was gated (i.e. 
synchronized to the respiratory signal). After injection, scans were acquired at 30 mins, 
1.5 hrs, 3 hrs, 6 hrs, 12 hrs and 24 hrs. A control experiment was performed, in which 
PBS was injected with no peptide nanofibers. A total of 5 mice were used for this 
experiment. 
Animal Models of AKI All animals were cared for at Baylor College of Medicine and 
according to the AIACU and Principles of Laboratory Animal Care of the National 
Institute of Health. Generation of Rockl-/- mice was previously described.68 Adult male 
C57BLKS mice (8 to 10 weeks old) were obtained commercially (Jackson Laboratory, 
Bar Harbor, ME). Mice received a single injection with 10 f.A.g/g body wt ofLPS (E. coli; 
List Laboratories, Campbell, CA) or sterile normal saline intraperitoneally. 42, 43, 45 For 
LPS-induced model of AKl, groups of 6 to 11 mice were randomly allocated to 
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individual groups. One group of mice was used as the control group. All other groups 
received a single intraperitoneal injection ofLPS (10 I-lg/g body weight). In LPS-treated 
animals, mice were injected with 0.8 ml of isotonic saline intraperitoneally to prevent 
hypovolemia after 12 hours.42 In experiments where the effect of preconditioned 
nanofibers was assessed, animals were given an injection ofnanofibers (200 I-lL) 
intraperitoneally 1 hour after LPS injection. Mice were sacrificed 24 hours after LPS 
injection. Urine albumin and creatinine were determined using Albuwell M and 
Creatinine Assay (Exocell, Philadelphia). Kidney ischemia reperfusion (I-R) was 
performed in male C57BLl6 mice, aged 8 to 10 weeks, obtained from Jackson 
Laboratory.61,62 Briefly, mice were anesthetized with intraperitoneal ketamine, had 
abdominal incisions, and then have both renal pedicles bluntly dissected. A 
microvascular clamp (Roboz) was placed on both renal pedicles for 30 minutes while the 
animal was kept at a constant temperature (37°C) and well hydrated. After ischemia, the 
clamps were removed, the wounds were sutured, and the animal was allowed to recover. 
Mice were randomly allocated into the following groups (n = 6): (1) sham; (2) 1-
R preconditioned nanofibers (100 I-lL) injected intraperitoneally 1 hour before induction 
of ischemia and at the time ofreperfusion; and (3) I-R nonconditioned nanofibers (100 
I-lL) injected intraperitoneally 1 hour before induction of ischemia and at the time of 
reperfusion. Mice were administered with 0.5 ml of isotonic saline intraperitoneally 
(preheated to 37°C) immediately after closure of abdomen, and sacrificed 24 hours after 
reperfusion. Serum creatinine and BUN were measured on obtained blood samples. 
Detection of Apoptosis. Apoptotic cells were determined using an Apoptag 
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Fluorescein In Situ Apoptosis Detection Kit (TUNEL assay; Chemicon, Billerica, MA), 
and by quantifying cytoplasmic histone-associated DNA fragments detection (Cell Death 
Detection ELISA; Roche, Indianapolis), according to the manufacturers' instructions. 
Caspase-3 activation was assessed by caspase-3 activation assay (BD Biosciences, San 
Jose, CA). 
In Situ Hybridization. In situ hybridization with an antisense PAI-l riboprobe was 
performed as described previously.69, 70 Total RNA from mouse lung was reverse-
transcribed into cDNA using Superscript reverse transcriptase (Clontech) and random 
hexamers (Sigma). PCR amplification was performed using T7-tagged forward and SP6-
tagged reverse primers to amplify a 848-bp fragment representing bases 663-1510 of the 
coding region of the murine PAI-l gene. The PCR-amplified cDNA template was used 
for in vitro transcription of digoxygenin- labeled riboprobe using T7 RNA polymerase for 
the antisense probe and SP6 for the sense control probe. 
Enzyme Cleavage Assays. Human recombinant osteopontin (1 I-tg, huOPN) mixed 
with 20 I-tL of nanofibers were cleaved by MMP3 (50 ng) in equal volume of cleavage 
buffer (200 mM NaCI, 50 mM Tris-HCI, pH 7.6, 5 mM CaCI2) for 10 minutes at 37°C as 
described previously72. The mixture of cleaved OPN fragments was separated on a 12.5% 
polyacrylamide gel under reducing conditions. The membrane was incubated in a 
combination of three primary anti-OPN antibodies, anti-OPN goat polyclonal antibody 
and two anti-OPN rabbit polyclonal antibodies, for 1 hour. Proteins were visualized with 
ECL Plus (GE Healthcare). 
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Statistical Analysis. All data are shown as mean ±SEM. Statistical significance was 
assessed by performing ANOVA followed by the Tukey-Kramer post hoc analysis for 
multiple comparisons using an a value of 0.05 in Graphpad Prism software (version 5.0; 
San Diego). Differences between paired means were assessed with the unpaired, two-
tailed t-test. 
Ethical Guidelines. All local and ethical guidelines of Rice University and Baylor 
College of Medicine were followed in the course of these experiments. Stem cells were 
transferred per agreement with Wisconsin Materials. Additionally, no materials involved 
in this study were used for commercial purposes. 
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Chapter 5: Multidomain Peptides as Biocompatible Single-Walled Carbon 
Nanotube Surfactants' 
Single-walled carbon nanotubes (SWCNTs) are an allotrope of carbon, similar to 
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graphene in that their structure is composed entirely of Sp2 carbon-carbon bonds. They 
are excellent thermal conductors and stronger than steel, making them attractive for use 
in construction of electronic devices1 and conductive polymers? Their high aspect ratio 
and inert nature also make them well-suited for use in biological environments.3 
Single-walled carbon nanotubes have also been recognized as exceptional near-IR 
fluorophores. They display unexcelled photostability, 4, 5 high optical anisotropy, 6 large 
Stokes shifts,7 and an absence of fluorescence intermittency. 4, 8 This unique combination 
of optical properties is not found in other emissive labels such as quantum dots or 
fluorescent dyes, making SWCNTs uniquely promising for applications as fluorescent 
markers and biosensors.9, 10 Although the maximum near-IR fluorescence quantum yields 
of SWCNTs are apparently only of order 10%, 11-13 their large absorption cross-sections 
and unusual emission wavelengths allow highly sensitive optical detection in biological 
environments.9, 14-17 However, certain challenges related to the nanotube surface coating 
need to be addressed before SWCNTs can realize their potential as biomarkers and 
sensors . 
. This chapter is based on two publications: 
Dmitri A. Tsyboulski, Erica L. Bakota, Leah S. Witus, John-David R. Rocha, Jeffrey D. 
Hartgerink and R. Bruce Weisman. Self-Assembling Peptide Coatings Designed for 
Highly Luminescent Suspension of Single-Walled Carbon Nanotubes. J. Am. Chem. Soc., 
2008, 130 (50), pp 17134-17140. 
Erica L. Bakota, Lorenzo Aulisa, Dmitri A. Tsyboulski, R. Bruce Weisman and Jeffrey 
D. Hartgerink. Multidomain Peptides as Single-Walled Carbon Nanotube Surfactants in 
Cell Culture. Biomacromolecules, 2009, 10 (8), pp 2201-2206. 
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A. The Case for Biocompatible SWCNT Surfactants 
The most obvious of these challenges is nanotube solubility. SWCNTs are highly 
hydrophobic and readily aggregate into nonemissive bundles, so they must be dispersed 
as individuals in order to provide the water compatibility needed for biological 
applications. Although covalent derivatization of SWCNTs has produced stable aqueous 
SWCNT solutions,18 chemical modification of the SWCNT sidewall locally perturbs the 
Sp2 structure of the tube, compromising the electronic and optical properties that make 
SWCNTs unique. Therefore, for many applications, noncovalent functionalization of 
SWCNTs is preferable. This usually involves processing the aggregated raw SWCNTs 
through sonication in surfactant solution followed by centrifugation. 19,20 This process 
yields stable dispersions of individualized, fluorescent SWCNTs noncovalently coated by 
surfactant. However, the choice of surfactant coating greatly affects the suitability of 
these dispersions for biological fluorescence applications. 
An appropriate noncovalent SWCNT surfactant should accomplish four objectives: 
First, the coating must confer low toxicity and high biocompatibility. Second, it should 
permit the SWCNTs to fluoresce with efficiencies comparable to those of pristine 
SWCNTs suspended in air or isolated in selected anionic surfactants. 11, 12 Third, the 
coating should be stable against displacement or disruption in biological environments, 
possibly through covalent cross-linking to form a shell around the nanotube. 17, 21 Finally, 
the SWCNT coating molecules should provide sites allowing chemical linkage of agents 
designed for biological targeting or specialized sensing?2 It is clearly challenging to meet 
all of these requirements at once. 
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The first class of surfactants used to solubilize SWCNTs was the class oftraditional 
anionic surfactants, such as sodium dodecylsulfate (SDS) and sodium 
dodecylbenzenesulfonate (SDBS). While these detergents suspend nanotubes well, they 
are highly toxic to mammalian cells due to surfactant-assisted dissolution of the lipid 
bilayer of the cell membrane.23,24 This violates the first goal of the desired SWCNT 
surfactant. 
This apparent toxicity sparked the development of many biocompatible agents for the 
noncovalent suspension ofSWCNTs. Until recently, the choice ofbiocompatible 
surfactants was limited to only a few materials, including Pluronics (synthetic nonionic 
surfactants),9, 15 single-stranded DNA (ssDNA),25 and bovine serum albumin (BSA).26 
However, the Pluronics do not easily permit selective chemical modifications that would 
allow the surfactant to perform other duties in vivo, such as cell-specific targeting. 
Furthermore, Pluronics, ssDNA, and BSA dampen fluorescence emission from carbon 
nanotubes. Therefore, to effectively and safely introduce disaggregated pristine SWCNTs 
into biological systems, new biocompatible surfactants are needed. 
Peptides are another class of materials that have shown promise as SWCNT 
surfactants.27-33 Peptides are particularly promising because they are relatively simple to 
synthesize, and their versatility allows them to form a variety of engineered structures 
with tailored functionalities. They are also generally less cytotoxic than detergents such 
as SDBS and are potentially able to be degraded by cellular enzymes. 
However, except in one case involving limited studies of bulk fluorescence,33 the 
emissive properties of SWCNTs in these peptide coatings have not been reported. To 
date, the rational design of peptide SWCNT coatings has focused on maximizing the 
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coating's affinity for the nanotube surface in order to achieve the greatest capacity for 
suspending SWCNTs in aqueous media,z8-35 This approach is not necessarily, however, 
directed at maximizing the emission efficiency of the suspended nanotubes. In this work, 
the fluorescence properties of SWCNTs suspended in different environments were 
examined, and it was shown that the surfactant exerts a profound influence on SWCNT 
emission efficiency. Furthermore, multi domain peptides appear to be a promising avenue 
for suspending single-walled carbon nanotubes. 
The influence of coating material on intrinsic SWCNT fluorescence efficiency is 
difficult to assess, because the brightness of a bulk sample will depend on the total 
nanotube concentration in suspension and the degree to which the suspended nanotubes 
are individualized (bundling quenches their emission),36, 37 in addition to the intrinsic 
coating-dependent fluorescence efficiency. We therefore applied near-IR fluorescence 
microscopy to make comparative brightness measurements on individual SWCNTs in 
dilute samples that differ only in their coating material. Figure 5.1 shows near-IR 
fluorescence images of dilute SWCNT suspensions in SDBS, Pluronic F127, ss-DNA, 
and BSA, obtained using fixed wavelength, circularly polarized excitation. Individual 
nanotubes in these images differ in apparent brightness because of the distribution of 
lengths, the distribution of (n,m) structures (governing absorptivity at the excitation 
wavelength), and the distribution of elevation angles relative to the observation 
direction.38,39 
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Figure 5.1. Near-IR fluorescence images of SWCNTs suspensions in aqueous SDBS, 
Pluronic F127, ss-DNA, and BSA. All images were recorded under identical conditions 
(excitation wavelength 658 nm, excitation intensity ...... 800 W/cm2, circular polarization, 
frame acquisition time 50 ms). Figure by Dmitri Tsyboulski. 
Nevertheless, it is clear from the differences in intensity scales that the ionic surfactant 
SDBS (which is not biocompatible) allows by far the strongest near-IR emission within 
this group. Individual SWCNTs in Pluronic suspension are at least a factor of 10 less 
bright than those suspended in SDBS, while SWCNTs in ss-DNA or BSA show even 
weaker emission. Pluronic and BSA coatings have the additional drawback of being 
vulnerable to displacement or coadsorption by proteins. 14 
B. Km(QL)nKm Series 
Here we have examined a series of multidomain peptides as SWCNT surfactants. 
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Multidomain peptides form nanofibers in aqueous solution, and these nanofibers have 
dimensions on the same size scale as SWCNTs, making them a promising lead in the 
search for suitable biocompatible surfactants. Initially, nine peptide sequences were used 
in this study to suspend SWCNTs. These are listed in Table 5.1 along with their simple 
designations: A - K7(QL)6K7, B - ~(QL)6~, C - Ks(QL)6KS, D - ~(QL)6~, E -
K3(QL)6K3, F - K2(QL)6K2, G - K2(QL)sK2, H - K2(QL)4K2, and I - K2(QL)3K2. 
Nanotubes were suspended in peptide solutions by placing -1 mg SWCNTs in an 
Eppendorfvial. A 1 wt% solution of peptide was prepared and pipetted directly on top of 
the dry SWCNTs. The vial was capped, shaken briefly, and tip-sonicated, followed by 3 
rounds of centrifugation. After discarding the pellets, their absorption and fluorescence 
spectra of the resulting peptide-SWCNT solutions were recorded. We consider the total 
suspended nanotube concentration to be proportional to the area under the measured 
absorbance spectrum, integrated between 500 and 1350 nm. The spectrally integrated 
fluorescence emission instead measures the relative concentrations of individually 
suspended nanotubes multiplied by their intrinsic fluorescence efficiencies in those 
suspending peptides. We found that SWCNT samples suspended in peptides E, F, and G 
yielded the highest concentrations of suspended nanotubes and also the highest total 
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emission intensities. The top frame of Figure 5.2 displays these three strongest emission 
spectra, while the bottom frame compares magnitudes of the spectrally integrated 
emission and absorption signals for all nine peptide coatings. We note that many of these 
magnitudes varied substantially from run to run, probably because of irreproducibility in 
the sonication of small volumes and in sampling the SWCNT raw material. Nevertheless, 
within the series of peptides, E, F, and G consistently gave the most concentrated 
SWCNT suspensions, with typical peak absorbance values exceeding 1 per cm. These 
samples appeared stable over periods of a few months, whereas the other peptide 
suspensions tended to form visible aggregates within days or weeks. 
Peptide Sequence Secondary Forms Nanofibers Solubilizes 
Structure SWCNTs 
A K7(QL)6K7 Random coil No No 
B ~(QL)6~ Random coil No No 
C Ks(QL)6KS Random coil No No 
D ~(QL)6~ Weak helix No Weakly 
E K3(QL)6K3 f3 -sheet Yes Yes 
F K2(QL)6K2 6 -sheet Yes Yes 
G K2(QL)sK2 f3 - sheet Yes Yes 
H K2(QL)4K2 Random coil No No 
I K2(QL)3K2 Random coil No No 
J K2(QF)sK2 P - sheet ? Yes 
Table 5.1. Multidomain peptides used as SWCNT surfactants. 
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Figure 5.2. a) Fluorescence emission spectra from bulk SWCNT samples suspended in 
peptide coatings E, F, and G. The spectra have been normalized to the most intense peak 
in peptide G. b ) Average spectrally integrated fluorescence emission and absorbance for 
bulk SWCNT samples suspended in the family of peptide coatings A-I, and in peptide J 
(normalized to the maximum values). Figure by Dmitri Tsyboulski. 
Figure 5.3 a,b,c,d shows 2D excitation-emission matrices of SWCNTs suspended in 
SDBS and in peptides E, F, and G. These data were recorded by scanning the excitation 
wavelength from 520 to 850 nm and the emission wavelength from 900 to 1300 nm. The 
excitation-emission maps reveal distinct peaks that can readily be assigned to particular 
(n,m) species by reference to established spectral studies of SWCNTs in aqueous sodium 
dodecylsulfate (SDS) suspension.7, 40 SDS is another anionic surfactant that is used 
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frequently to solubilize SWCNTs. However, SDS is also highly toxic to cells, causing 
dissolution of the lipid bilayer of the cell membrane. We note that the SWCNT spectral 
peak positions and widths depend significantly on suspending agent. Excitation and 
fluorescence peaks corresponding to the second (E22) and first (Ell) van Hove transitions 
of disaggregated SWCNTs are progressively shifted to longer wavelengths in peptides G, 
F, and E as compared to the peak positions in aqueous SDBS. It is often considered that 
such red shifts arise from more polarizable nanotube environments?O, 41-43 The Ell 
fluorescence bands also broaden progressively for SWCNTs suspended in peptides G, F, 
and E. This broadening is illustrated in Figure 5.3 f, which shows bulk emission spectra 
near the (6,5) peak. Using standard peak-fitting procedures, we deconvoluted the 
overlapping emission features and deduced (6,5) spectral line widths of .... 200, 240, 320, 
and 480 em-I, respectively, in SDBS and peptides G, F, and E. As expected, the 
corresponding E22 excitation profiles shown in Figure 5.3 e have much smaller variations 
because those spectral widths arise from relaxation processes that are internal to the 
nanotubes and relatively insensitive to environment. 
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Figure 5.3. 2D excitation-emission photoluminescence maps of SWCNTs suspended in 
a) SDBS; b) Peptide G; c) Peptide F; d) Peptide E. White spots in (b, c, d) mark peak 
positions of SWCNTs in aqueous SDBS. e,f) Excitation and emission spectral profiles 
near (6,5) SWCNT peaks in various surfactants. Figure by Dmitri Tsyboulski. 
It has been suggested that SWCNT emissive quantum yields also depend on 
coating.20 However, the influence of SWCNT/surfactant interactions on fluorescence 
efficiency is not yet well documented or understood. Bulk spectroiluorimetric techniques 
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do not provide a reliable tool for such quantitative comparisons, because even when the 
fluorescence signals of bulk SWCNT suspensions are normalized to the mass of 
suspended carbon in the sample, the results can be substantially influenced by small 
nanotube bundles that may remain after ultracentrifugation. As was recently 
demonstrated by Crochet et al.,36 further purification of SWCNT suspensions by a density 
gradient fractionation technique can give a -20-fold increase in the fluorescence signal 
per unit of SWCNT mass. 
An incisive method for comparing emission efficiencies of SWCNTs is to measure 
the fluorescence of individual nanotubes. 12 Because energy transfer to metallic SWCNTs 
tends to make nanotube bundles nonemissive,19 their presence is unlikely to interfere with 
such measurements. A near-IR fluorescence microscope/spectrometer was used to 
capture emission images of dilute, freshly prepared suspensions of SWCNTs in peptides 
E, F, and G (Figure 5.4). These were recorded under the same experimental conditions as 
the data of Figure 5.1. It was found qualitatively that SWCNTs coated with peptide G 
displayed significantly brighter emission than those suspended in peptide E, peptide F, 
Pluronic, ss-DNA, or BSA. 
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Figure 5.4. Near-IR fluorescence images of SWCNTs suspended in peptides E, F, G, and 
J. Images were recorded under identical conditions (658 nm excitation, ..... 800 W/cm2 
excitation intensity, 50 ms image acquisition time) and plotted with the same false-color 
intensity scale. Figure by Dmitri Tsyboulski. 
To quantify these differences in emission efficiencies, it was necessary to avoid the 
complicating effects of sample heterogeneity in length, (n,m) structure, orientation, and 
defect density. This was achieved through measurements on individual SWCNTs in 
aqueous suspension that were selected to meet several criteria: length greater than 2 J!m 
(to allow optical resolution); low defect density (estimated from uniform emission along 
the nanotube length); Ell peak spectral position matching the value found in bulk 
fluorescence spectroscopy for a known (n,m) species; and free motion indicating that the 
SWCNT was not attached to a glass surface. 
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Figure 5.5. Comparison of emission intensities and spectra of SWCNTs in different 
surfactants. Near-IR fluorescence images of individual (11,3) nanotubes suspended in 
peptide G (top) and Pluronic F127 (bottom) recorded under the same experimental 
conditions and plotted using the same false-color intensity scale. Figure by Dmitri 
Tsyboulski. 
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Figure 5.5 shows images and emission spectra of such selected nanotubes coated by 
peptide G and Pluronic F127. Using the method and apparatus described previously, 12, 44 
we measured the spatially and spectrally integrated emission signal from each nanotube 
with calibrated excitation intensity and calibrated detection sensitivity to find the absolute 
product of SWCNT absorption cross section cr and fluorescence quantum yield <DF1 • This 
product, cr <DFt, is the fluorescence action cross section. For each SWCNT coating studied 
here, we analyzed at least 10 nanotubes of various structural (n,m)-types to obtain the 
results given in Table 2 and Figure 5.6. Table 5.2 shows that the intrinsic brightness of 
individual SWCNTs is significantly affected by the surfactant coating. Using the 
available data, we computed the intrinsic brightness of each coating relative to that in 
SDBS by averaging the measured ratios of cr(A22)<DFI for corresponding (n,m) species. (A22 
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denotes the E22 peak wavelength.) The resulting relative fluorimetric brightness values, 
which are listed in the last row of Table 5.2, range from 0.05 to 0.46. Notably, these 
values are strongly correlated with the spectral line widths of the near-IR emission bands, 
as will be discussed below. 
0""'22) x <l>F( (104 cm2/mol C); (number ofSWCNTs measured) 
SWCNT SDBS K3(QL)6K3 K2(QL)6K2 K2(QL)sK2 K2(QF)sK2 Pluronic 
species (El (F) JGl ill F127 
(8,3) 21 1.2 (1) 8.9 (2) 
(7,5) 19 0.76 (3) 5.1J21 5.8JJ1 3.1 (1) 
(7,6) 14 0.63 (4) 4.5~~) 2.0 (2) 
(10,2) 27 9.8 (3) 21 (7) 
(12,1) 17 0.98 (3) 1.8 (1) 1.5 (1) 
(11,3) 18 1.7(4} 3.3{~ 1.5 (4) 
(10,5) 12 1.5 (4) 0.80 (3) 
(9,7) 10 1.1 (1) 0.83 (1) 
Relative 1 0.050 ± 0.11 ± 0.01 0.32 ± 0.09 0.46 ± 0.22 0.13 ± 
fluorimetric 0.009 0.04 
brightness 
Table 5.2. Fluorescence action cross-sections of selected SWCNT species in various 
surfactants. 
106 0 SOBS () A Peptide G 
15 0 Pluronic F127 
E Q a 
-
g g ~ gO N 5 105 ,a g gO 
.:. ~ u.. ~I e ~ -~ tr1Q4 
0.8 0.9 1.0 1.1 
Diameter (nm) 
Figure 5.6. Measured fluorescence action cross sections of selected SWCNT structures 
suspended in aqueous SDBS ( 0), peptide K2(QL)sK2 (0) ( 6.), and Pluronic F127 (0). 
Data for SWCNTs in SDBS are taken from reference 12. Figure by Dmitri Tsyboulski. 
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It is interesting to examine the relationship between the ability of a peptide to self-
assemble into nanofibers and its ability to individually suspend and allow emission from 
SWCNTs. Figure 5.2 illustrates that peptides E, F, and G are the ones within the 
Kn(QL)mKn series most effective in suspending SWCNTs. Interestingly, these peptides 
are also the only ones that can assemble into nanofibers. K2(QL)6K2 (peptide F) forms 
exclusively ~-sheet nanofibers -100-150 run in length, while K3(QL )6K3 (peptide E) 
and K2(QL)sK2 (peptide G) self-assemble into mixtures ofnanofibers and micelles of 
various lengths and sizes. This behavior is illustrated by the cryo-TEM images of Figure 
5.7 a,b,c, which were acquired from solutions of pep tides E, F and G without nanotubes. 
Figure 5.7 d,e,f shows corresponding cryo-TEM images for these peptides in the presence 
of SWCNTs. It can be deduced that the added SWCNTs act as templates for peptide self-
assembly. Frame 5.7e clearly shows a number ofnanotubes visible as extended structures 
with lengths of -300 run or more, along with shorter fibrils composed of self-assembled 
~-sheets of peptide F as formed in the absence ofSWCNTs. Figure 5.7 d and f show that 
the peptides E and G adsorb onto and suspend SWCNTs in preference to forming fibrils 
and empty micelles. The peptides most effective at SWCNT suspension seem to be those 
that have some tendency to self-assemble in the absence of nanotubes. Although the 
geometry of peptide F is ideal for forming independently self-assembling nanofibers, the 
geometrical requirements for wrapping a SWCNT are apparently somewhat different and 
favor peptide G, which has a slightly shorter amphiphilic region. This selectivity between 
closely related peptide sequences also demonstrates that these peptides are not 
solubilizing the nanotubes as a simple amphiphilic surfactant. Instead, the peptides 
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interact with the nanotubes in a more specific fashion in which their tendency to 
anisotropically self-assemble is reinforced by the presence of the SWCNT. 
Figure 5.7. Cryo-TEM images of peptide solution samples. a, b, c) Peptides E, F, and G 
peptides without SWCNTs. d, e, f) Peptides E, F, and G with added SWCNTs. Scale bars 
are 100 nm. 
Further insights into the nanotube-peptide interface can be obtained from optical 
measurements, because nanotube spectral peak positions reflect the local dielectric 
environment.41 -43 The broadened near-IR emission features found for SWCNTs coated by 
peptides E and F suggest a nanotube environment that is non-uniform and imperfect. By 
contrast, the sharper spectral features observed using peptide G indicate a more uniform 
coating morphology. 
Our findings suggest a general principle useful for developing high-performance 
SWCNT-based fluorescent labels and sensors. Biopolymers with tendencies to self-
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assemble into extended supramolecular structures are promising candidates for 
noncovalently suspending SWCNTs and preserving their optical properties. However, the 
best results are found using peptides (such as G) that are imperfect assemblers in the 
absence of an external template such as a SWCNT. Peptide-based SWCNT coatings have 
historically been designed to provide the highest water solubility of carbon nanotubes. 
This approach should optimize the peptide's ability to suspend individual nanotubes in 
aqueous environments but will not necessarily achieve the goal of maximizing SWCNT 
fluorescence intensity, nor will it necessarily incorporate bio-targeting ability via cell-
signaling sequences in the peptide. 
c. Effects of Peptides on Fluorescence Emission Efficiency 
Within the Km(QL)nKm series, peptide G gave the most intense SWCNT near-IR 
fluorescence. In an attempt to further raise the emission efficiency, we studied a related 
structure, K2(QF)sK2 (peptide J), in which the leucine residues (L) were replaced by 
aromatic-containing phenylalanine residues (F). The importance of aromatic groups in 
surfactants used to suspend SWCNTs has been discussed previously.4s We used the 
methods described above to characterize SWCNTs coated with the new peptide J and 
found a fluorescence efficiency -40% higher than that with peptide G (see Figures 5.2 b 
and 5.4). The measured values are listed in Table 5.2. 
Examination of our single-nanotube measurements of line widths and emission 
efficiencies reveals a striking correlation. As shown in Figure 5.8, coatings that give 
sharper emission peaks also give the highest emission efficiencies. We presume that the 
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variations in emission efficiencies reflect coating-related differences in nonradiative 
decay rate of the emitting excitonic state. One possible mechanism is that less uniform 
coatings lead to accelerated exciton decay as portions of the nanotube surface are 
exposed to perturbation by the surrounding solution. The data for relative emission 
efficiency vs spectral line width 8v can be fit by the decaying exponential function 
plotted as a solid curve in Figure 5.8: 
Relative emission = 160 • exp (-ov/22 cm- 1) + 0.05 (1) 
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Figure 5.8. Relative emission intensities measured for individual aqueous SWCNTs in 
six coatings (taken from the last row of Table 5.2) as a function of emission line widths. 
Line width values in this plot were taken from measurements only on (10,2) nanotubes to 
avoid structure-dependent line width effects. Error bars on the x-axis represent the full 
range of measured values, not standard deviations. The solid curve is an exponential best 
fit to the data. Figure by Dmitri Tsyboulski. 
When extrapolated to air-suspended SWCNTs, for which the reported (10,2) line width is 
- 100 cm -1,46 the equation predicts an emission efficiency nearly twice that of nanotubes 
in aqueous SDBS suspension. The physical basis for this exponential relation remains to 
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be explored through further study. We note that spectral line widths measured in bulk 
samples contain additional inhomogenous broadening, 12, 37,44 and so will not obey the 
relation of equation 1. Nevertheless, properly prepared bulk samples seem to show a 
coating-dependent spectral width variation parallel to that found for individual nanotubes. 
Our findings therefore suggest that one can estimate the relative brightness of individual 
SWNCTs in different coating environments through simple bulk spectroscopy rather than 
through demanding measurements involving single-nanotube fluorescence microscopy. 
Single-nanotube photometric measurements under controlled conditions have shown 
that the intensity of near-IR emission from SWCNTs in aqueous suspension depends 
strongly on the coating material. Emission in common biocompatible surfactants such as 
Pluronic F127, ss-DNA, and BSA is weak relative to that in SDBS. This work has 
identified that multidomain peptides should allow biocompatibility with improved 
SWCNT emission. The self-assembling properties of these multidomain peptides were 
found to correlate strongly with their ability to suspend nanotubes and preserve their 
emission efficiency. The peptides that allowed the brightest SWCNT emission were not 
those that displayed the strongest tendency to self-assemble, but rather those with similar 
but slightly modified structures and weaker self-assembly tendencies. 
~--------~-------
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D. Biocompatibility of Peptide SWCNT Surfactants 
1. Sequence Modifications Confer Biocompatibility 
After the initial series of multi domain peptides had shown to suspend carbon 
nanotubes while allowing satisfactory fluorescence emission, the biocompatibility of 
these peptides was investigated. When multidomain peptides from the series Kn(QL)mKn 
were added to cell culture medium to assess their compatibility with biological systems, it 
was found that peptides bearing the positively charged residue lysine in the charged 
domain had a tendency to aggregate in the culture medium. Aggregation occurred 
regardless of whether single-walled carbon nanotubes were present. It is likely that 
negatively charged phosphate ions in the cell culture medium interacted with positively 
charged lysine residues, effectively screening the charge on these terminal residues. As 
the charge on the terminal residues was reduced, the individual peptides no longer 
repelled one another and self-assembled into gel-like aggregates. When a suspension of 
SWCNTs in aqueous K2(QL)sK2 was added to a culture of NIH 3T3 cells, the aggregates 
formed were large enough to be easily visible with a standard light microscope (Figure 
5.9). To avoid this problem, we prepared analogous peptides in which the positively 
charged lysine was replaced by the negatively charged glutamic acid. When such 
peptides displaying glutamic acid as the terminal residues were added to cell culture 
medium, no visible aggregates were detectable via light microscopy. This observation 
lends evidence for the lysine-phosphate interaction that is suspected to take place in the 
cell culture medium. Therefore, for cytotoxicity studies, the multi domain peptides 
E(QL)6E and E(QL)6EGRGDS were used instead (Figure 5.10). 
Figure 5.9. Light microscope images of NIH 3T3 fibroblasts incubated with SWCNT 
suspensions in a) K2(QL)sK2 and b) E(QL)6E. The brown area in the lower portion of 
panel a) is a gel-like aggregation of peptide-coated SWCNTs. 
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Figure 5.10. Structure of multi domain peptide a) E(QL)6E and b) associated nanofibers. 
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2. Characterization of Peptide-SWCNT Suspensions 
To ensure that the SWCNT suspensions being added to cell cultures contained 
individual SWCNTs and not aggregates, AFM of the SWCNT solutions was performed 
(Figure 5.11). This also allowed visualization of the peptide nanofibers to confirm that 
the predicted self-assembly of the peptides was taking place. The absence of large 
bundles of either peptide or SWCNTs in the AFM images indicated that the SWCNTs 
were well-dispersed by the peptide. Furthermore, height profiles measured from AFM 
images were consistent with the dimensions of individual SWCNTs coated by peptides. It 
was noticed that peptide-suspended SWCNTs visible by AFM appear to be 
approximately 100 nm in length, shorter than would be predicted by the length 
distribution of HiPCO-produced SWCNTs. AFM of SWCNTs suspended in SDBS (but 
prepared under identical suspension conditions to those ofpeptide-SWCNT samples) 
show some longer SWCNTs, although these nanotubes appear somewhat aggregated. 
Figure 5.11. AFM images of SWCNTs suspended in a) E(QL)6E and b) 
E(QL)6EGRGDS. 
This suggests that these multi domain peptides are selectively suspending shorter 
SWCNTs. We also measured near-IR fluorescence spectra of each freshly prepared 
SWCNT suspension, using laser excitation at 659 and 784 nm (Figure 5.12). These 
measurements provide additional information about the aggregation state of the 
suspended nanotubes, since SWCNT bundling quenches fluorescence. Fluorescence 
spectra normalized to sample absorbance values reveal that of the biocompatible 
surfactants, E(QL)6E allows better fluorescence efficiency than either of the Pluronic 
surfactants, while E(QL)6EGRGDS is intermediate to the two Pluronics. 
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Figure 5.12. Fluorescence emission spectra of SWCNT suspensions in different 
surfactants, with 659 nm excitation. Curves have been normalized according to the 
sample absorbance to show relative fluorescence efficiencies. 
3. Peptide Cytotoxicity 
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In our cytotoxicity studies, NIH 3T3 fibroblasts were seeded in each well of a 24 well 
plate and allowed to incubate overnight. The following day, the peptide or peptide-
SWCNT solutions were added directly to the cell wells. Cells were detached from the cell 
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culture plate with trypsin at 48 h, stained with Trypan blue, and then counted using a 
hemocytometer. For every concentration of surfactant or surfactant-SWCNT suspension 
tested, there was a negative control, which consisted of NIH 3 T3 cells with no solutions 
added. Cell viabilities were normalized against these negative controls for each condition. 
The data were analyzed by two-way ANOV A, and the more subtle differences between 
specific surfactants were analyzed by one-way ANOVA (Figure 5.13). The one-way 
ANOV A results indicated that at the lowest concentration (150 11M) SDBS did not show 
statistically significant toxicity. At 300 11M and 1 mM concentrations, however, cell 
viability for SDBS-incubated cultures dropped to zero, a toxicity that was statistically 
significant compared with every other surfactant. This confirmed that SDBS is highly 
cytotoxic and unsuitable for use in mammalian cell culture. Although the multidomain 
peptides E(QL)6E and E(QL)6EGRGDS did appear to show some dose-dependent 
cytotoxicity, this cytotoxicity was not significantly different from the Pluronic series at 
150 and 300 11M concentrations. That is, t tests comparing cell viability between different 
surfactants at 150 and 300 11M yielded P values above 0.05 for every possible comparison 
of two surfactants, except for the comparison of SDBS-incubated cultures with all other 
cultures at 300 !lM (as SDBS shows substantial toxicity at this concentration). As 
Pluronic and peptide toxicities are not significantly different from one another at or 
below 300 11M, the peptides explored here provide viable options for delivering 
nanotubes in vitro at low concentrations. At 1 mM surfactant concentration, however, the 
toxicity of the multi domain peptides becomes more apparent, with both peptides showing 
toxicities significantly higher than the Pluronics (P < 0.05). 
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Figure 5.13. Cell viability of NIH 3T3 cells incubated for 48 h with 150 JlM, 300 JlM, 
and 1 mM surfactants. Half of the groups were incubated with single-walled nanotubes 
(shown in solid blue) and half of the groups were incubated in the absence ofnanotubes 
(shown in black and white). 
This toxicity may be due to the peptides themselves or may be due to impurities in the 
peptide preparations. The latter scenario is likely, as peptides capped by glutamic acid 
residues cannot be purified by HPLC and therefore retain many of the impurities 
introduced during peptide synthesis. 
4. Single-Walled Carbon Nanotube Cytotoxicity 
Analysis by two-way ANOVA makes it possible to distinguish which set of variable 
factors (surfactants or the presence of SWCNTs) is responsible for deviations from the 
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control, or whether the observed toxicity is caused by a combination of these two sets of 
factors. Because half of the experiments contained surfactants without SWCNTs and the 
other half contained surfactant-suspended SWCNTs, this provided an opportunity to 
assess the cytotoxicity of carbon nanotubes in vitro. This analysis revealed that single-
walled carbon nanotubes showed no significant cytotoxicity, regardless of the identity or 
concentration of the surfactant. We found that the two-way ANOVA yielded a P-value 
above 0.05 for all comparisons collectively of SWCNT and non-SWCNT incubated cells 
(P = 0.5342, 0.9501, and 0.4345 for 150 11M, 300 11M, and 1 mM, respectively). The two-
way ANOVA analyses also suggest that the combination of peptide with SWCNT is not 
responsible for any toxicity observed at surfactant concentrations of 150 or 300 11M (P> 
0.05). A P-value of 0.0438 was obtained for the interaction of peptide surfactants with 
SWCNTs at the 1 mM concentration. However, SWCNTs themselves showed no toxicity 
at this concentration, casting doubt on the practical significance of this result. Thus, we 
conclude that there is no evidence for synergistic toxicity effects involving single-walled 
carbon nanotubes and peptide surfactants, at least at 150 11M and 300 11M concentrations. 
Examination of cell morphology by light microscopy revealed that cells incubated in 
solutions of SDBS, with or without nanotubes, showed a rounded morphology indicative 
of a lack of cellular anchoring to the cell well plate (Figure 5.14 a). A rounded 
morphology precedes cell death, and indeed, cultures incubated at SDBS concentrations 
of 300 11M or higher experienced total cell death. By contrast, cell morphology in the 
presence ofPluronic F68, F127, E(QL)6E, and E(QL)6EGRGDS appeared normal. Figure 
5.14 b-d shows healthy cells in each of these conditions. These cells are spread out and 
anchored to the cell culture wells, morphology that is typical for fibroblasts. 
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Figure 5.14. Cell morphology of NIH 3T3 cells after 24 h of incubation with a) SDBS, b) 
Pluronic F68, c) E(QL)6E, and d) E(QL)6EGRGDS. 
After 48 h, cells were imaged with a near-IR fluorescence microscope. Imaging was 
performed through the cell culture plates so as not to disturb cell morphology. This 
allowed us to assess the interaction of SWCNTs with the cells as well as the amount of 
soluble peptide-wrapped SWCNTs remaining in solution. It was found that at 48 h, 
significant amounts of nanotubes still remained in solution. Interactions between 
SWCNTs and 3T3 cells were also observed (Figure 5.15). 
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Figure 5.15. NIH 3T3 cell in the presence of single-walled carbon nanotubes suspended 
in E(QL)6EGRGDS. The image shows near-IR fluorescence from the nanotubes, false-
colored according to intensity. Bright spots indicate carbon nanotube clusters inside the 
cell body. Image from Dmitri Tsyboulski. 
E. Conclusions 
For single-walled carbon nanotubes to be used in many biological applications, 
suitable biocompatible surfactant coatings that noncovalently functionalize the SWCNTs 
are needed. N oncovalent surfactants wrap and solubilize carbon nanotubes while 
preserving their unusual electronic structure and optical properties. Standard ionic 
surfactants are highly cytotoxic, whereas traditional "biocompatible" surfactants such as 
Pluronic do not readily allow chemical modification. The alternatives presented here are 
customizable multi domain peptides that noncovalently modify SWCNTs by wrapping the 
nanotubes inside ~-sheet nanofibers. The cytotoxicity of carbon nanotubes remains 
controversial. Some reports show a lack of toxicity ,9, 47, 48 while others find the opposite 
effect. 49, 50 In comparative studies, we find statistically significant differences between 
the viabilities of cultured cells incubated with SWCNTs suspended by different 
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surfactants. However, analysis indicates that the cytotoxicity arises from the surfactants 
rather from the SWCNTs or from synergistic effects between nanotubes and surfactants. 
We therefore suggest that it is not necessarily the SWCNTs that may be cytotoxic, but 
rather the agents in which they are suspended and their aggregation state. Our two-way 
ANOVA analysis shows that, within the concentration range used here, disaggregated 
SWCNTs do not influence the viability of the 3T3 cells in culture. Thus, single-walled 
carbon nanotubes seem to be acceptably nontoxic for in vitro biological applications as 
long as the surfactants used to suspend them are effective and nontoxic. We find that the 
new multi domain peptides are approximately as nontoxic as the Pluronic surfactants, and 
that they allow comparable SWCNT fluorescence efficiency while offering options for 
simple chemical customization. Our qualitative findings are summarized in Table 5.3. 
Because peptides allow for a wide range of chemical functionalities, one can design 
surfactants that are both nontoxic and provide biological specificity, such as enhanced 
integrin binding through the RGD sequence on the C-terminus ofE(QL)6EGRGDS. We 
have shown that such cell-adhesion sequences may be incorporated without 
compromising the ability of the peptide to self-assemble. This suggests that other cell-
adhesion sequences and targeting moieties can also be incorporated into the multi domain 
peptides, enabling important new biological applications of carbon nanotubes. 
Furthermore, peptides may undergo hydrolysis in vivo through the action of various 
peptidases naturally found in the body, providing a starting point for metabolism of 
peptide-based surfactants. This biodegradation is essential if a potentially toxic buildup of 
surfactant is to be avoided. These qualities extend the general range of applications of 
peptide surfactants far beyond that of traditional Pluronic surfactants. 
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Covalent SDBS Pluronics Lys- Glu-
Modification capped capped 
pep tides peptides 
Suspension Stability good good fair good* good 
Fluorescence/ poor good fair good fair 
Absorbance 
Cytotoxicity vanes poor good N/A good 
Table 5.3. Summary of properties of different single-walled carbon nanotube surfactants 
*Suspensions of SWCNTs are stable at room temperature for weeks or months outside of 
cell culture conditions. However, when added to cell culture, although the SWCNTs 
remain stably suspended, the entire suspension forms a hydrogel. 
F. Experimental 
Peptide Synthesis and Purification. Peptides were synthesized on a 0.15 mmol scale 
with an Advanced Chemtech Apex 396 peptide synthesizer using standard Fmoc 
chemistry, as described in Chapter 3. 
Preparation of SWCNTIPeptide Suspensions. Peptides were first dissolved in 
ultrapure water at a concentration of 10 mg/mL. Single-walled carbon nanotubes grown 
in the Rice University HiPco reactor (batch HPR 161.1) were used without further 
purification. SWCNT samples of -1 mg were weighed out and placed in 1.5 mL 
Eppendorftubes. To these were added 1 mL of the peptide solution with pH adjusted to 
7. The mixtures were then sonicated for 11 s using a Microson XL 2000 tip sonicator at a 
power level of 5 W. The sonicator probe was immersed to approximately one-half the 
solution depth. Each sample was then centrifuged for 5 min in a Sorvall Biofuge Pico 
centrifuge at 10,000 x g. The supernatant was decanted and centrifuged for an additional 
10 min, followed by another round of decanting and centrifugation. The parameters in 
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this protocol were chosen to maximize sample fluorescence intensities. Although 
centrifugation helps to separate aggregated from individually suspended nanotubes, even 
extensive ultracentriguation does not entirely remove small bundles. 19, 36 We note that the 
presence of bundles does not affect our single-nanotube measurements. 
Vis-NIR Absorbance and Fluorescence. Bulk absorbance and fluorescence 
measurements were collected on an NSI NanoSpectralyzer (Applied NanoFluorescence, 
LLC). Excitation-emission fluorescence maps were measured on bulk SWCNT samples 
using a Fluorolog 3-211 spectrofluorometer (Horiba J-Y) equipped with a single-channel 
liquid nitrogen cooled InGaAs detector. 
Near-IR Imaging ofSWCNT Suspensions. Near-IR fluorescence imaging and 
spectroscopy of individual SWCNTs were performed using a custom-built apparatus 
described previously.44 It is based on an inverted Nikon TE-2000U microscope with a 
Nikon PlanApo VC 60 x /1.4 NA oil-immersion objective. A combination of a dichroic 
beamsplitter and a dielectric 946 nm long-pass filter was used to select emission 
wavelengths greater than 950 nm. A liquid nitrogen cooled InGaAs camera (Roper 
Scientific OMA-V 2D) sensitive between 900 and 1600 nm was installed on one 
microscope output port. Another output port was coupled via optical fiber to the input slit 
ofa C140 spectrograph (Horiba J-Y) equipped with a 512-element InGaAs array (OMA-
V, Roper Scientific). In this way near-IR emission spectra could be acquired from a 
selected spatial region of -1.5 x 1.5 ~m at the sample. We excited samples with 
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circularly polarized beams from diode lasers emitting at 658 and 785 nm. The circular 
polarization ellipticity was ~0.95. 
Cryo-TEM Measurements. 10 /-lL of peptide-SWCNT suspension was placed on a 
holey carbon-coated copper grid (Quantifoil, 1.2/1.3 400 mesh) and gently blotted with 
filter paper using an FEI Vitro bot, forming a thin film on the grid. The grid was dropped 
into liquid ethane and then transferred into liquid nitrogen. Images were acquired using a 
JEOL 2010 transmission electron microscope at an accelerating voltage of200 kV. 
Atomic Force Microscopy (AFM). SWCNT-peptide solutions were diluted 20-fold 
with ultrapure water and were dropped onto freshly cleaved mica while spinning on a 
Headway Research, Inc. photoresist spinner. Samples were rinsed with deionized water 
for 1-2 s and then spun for an additional 10 min. AFM images were collected as 
previously described. 
Cell Culture. NIH 3T3 mouse fibroblasts were obtained from the American type 
Culture Collection and were cultured in Coming 75 cm2 cell culture flasks. Dulbecco's 
modified Eagle medium (Gibco) was supplemented with 10% FBS and 1 % penicillin-
streptomycin v/v. Cells were cultured in an incubator at 37°C at 5% C02 and the 
medium was changed approximately every 2 days. Propagation of this cell line required 
cells to be passaged every 6-7 days. For the toxicity experiments, 5 x 104 cells were 
placed in wells in a 24-well plate and allowed to incubate overnight. A 15 mM stock 
solution of peptide or peptide-SWCNT suspension was added to reach the desired 
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concentrations of 150, 300, and 1000 J.LM. The cells were then incubated for an additional 
48 h. At 48 h, cells were detached from the wells with trypsin and stained with Trypan 
Blue. Viable cells exclude Trypan blue from the cell, while the dye leaks into dead or 
injured cells. Cells were then counted using a hemocytometer (Hausser Scientific) and 
Nikon Eclipse E400 optical microscope. 
Near-IR Imaging of 3T3 Cells Exposed to SWCNT Suspensions. Near-IR fluorescence 
imaging of3T3 cells was performed using a custom-built apparatus based on an inverted 
Nikon TE-2000U microscope with a Nikon PlanApo VC 60x /1.4 NA oil-immersion 
objective25 . A combination of a dichroic beam splitter and a dielectric 946 nm long-pass 
filter was used to select emission wavelengths greater than 950 nm. A liquid nitrogen 
cooled InGaAs camera (Roper Scientific OMA-V 2D) sensitive between 900 and 1600 
nm was installed on one microscope output port. Another output port was coupled via 
fiberoptic cable to the input slit ofa J-Y C140 spectrograph equipped with a 512-element 
InGaAs array (OMA-V, Roper Scientific). In this way, near-IR emission spectra could be 
acquired from a spatial region of -1.5 x 1.5 J.Lm at the sample. We excited samples with 
circularly polarized beams from diode lasers emitting at 658 and 785 nm. The circular 
polarization ellipticity was ~0.95. 
One and Two-Way ANOVA. Analysis of variance (AN OVA) was performed using 
Prism software. Two-way ANOV A was performed to determine whether the interaction 
of SWCNTs with the surfactant affected the solution toxicity, while one-way ANOV A 
and Tukey tests were used to compare each condition with every other. 
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Chapter 6: Conclusions 
Self-assembly is a powerful process that utilizes various noncovalent interactions to 
direct the construction of more complex nanostructures. While self-assembly is 
widespread in biology, peptides and proteins are particularly stunning examples of what 
structures and functions are possible as a result of this assembly. Over the past four years, 
I have attempted to harness the potential of supramolecular chemistry to construct a 
library of multi domain peptides that self-assemble into discrete nanofibers. These 
peptides assemble under the influence of charge screening, forming a dense fibrous 
network that is often accompanied by the transition from liquid to gel. Within the realm 
of multi domain peptides, I have shown that variation of particular amino acids in the 
primary structure can lead to changes in the secondary structure, as well as changes in the 
mechanical properties of the resulting hydro gels. Variation of the charged amino acids in 
the peripheral block has resulted in peptides that are compatible with cell culture. 
Substitution of the hydrophilic amino acids in the central block leads to changes in the 
hydrogen bonding network on the hydrophilic exterior of the fiber, which in turn leads to 
changes in the rigidity of the gel. Substitution of the hydrophobic amino acids in the 
central block of the peptide introduces new interactions into our self-assembly scheme: 
the introduction of 3t-3t stacking interactions. This 3t-3t stacking exerts some influence 
over the self-assembly process, leading to changes in the secondary and tertiary structure 
of the peptides. Each subtle change can be used to tailor the multi domain peptide for 
unique applications. 
Although multidomain peptides hold a world of promise in many fields, two specific 
applications were discussed here. The first of these is to use a multidomain peptide 
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hydrogel, specifically E2(SL)6E2GRGDS, as a controlled-release medium for the delivery 
of compounds secreted by embryonic stem cells. Stem cells are known to secrete a 
variety of therapeutic compounds, some of which we were able to identify. These include 
osteopontin, follistatin, ICAM-5, CCRIO, and adiponectin. Many of these compounds 
can be absorbed and released by multidomain peptide gels, and collectively this 
secretome was shown to alleviate the increased cell permeability that is associated with 
kidney injury in vitro. After encouraging in vitro results, the rheological properties of the 
E2(SL)6E2GRGDS hydrogel were investigated. It was found that E2(SL)6E2GRGDS is 
ideally suited to injection via syringe and needle: the hydrogel is not only stable over 
time, but shows the ability to recover immediately after needle shear. The ability to 
recover within just seconds of the shearing event allows the gel reform after flowing 
through the needle rather than remaining in a liquefied state. This allows the gel to 
remain localized in the area of injection rather than flowing away from the target area. 
Finally, with this knowledge, E2(SL)6E2GRGDS hydrogels were tested in vivo and shown 
to improve kidney function in mice with induced kidney damage. Reduction in the 
urinary albumin/creatinine ratio, coupled with significant decreases in serum BUN and 
creatinine levels, indicates an improvement in overall kidney function in these animals. 
Together, these promising results indicate that peptide hydrogels are good candidates for 
drug delivery materials, and that this system provides a cell-free alternative to current 
stem cell therapies. 
A second application of multidomain peptides discussed was the use of peptides as 
surfactants for single-walled carbon nanotubes. One of the primary obstacles for carbon 
nanotube-based therapies is the insolubility of nanotubes in virtually every solvent. 
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Although research into appropriate surfactants for nanotubes has been extensive, few 
surfactants exist that actually preserve the properties that make SWCNTs attractive 
(namely, fluorescence) while remaining biocompatible. Several multidomain peptides 
solve this problem: K3(QL)6K3, K2(QL)6K2, and K2(QL)5K2. Each of these peptides forms 
j3-sheet peptide nanofibers that are capable of encapsulating the carbon nanotube. 
K2(QL)5K2 seems to show less of a propensity for nanofiber formation than K3(QL)6K3 or 
K2(QL)6K2, yet it solubilizes SWCNTs extremely well, indicating that the peptide may 
actually use the SWCNT as a template for fiber formation. These multidomain peptides 
also preserve the fluorescence properties of the SWCNT, a property that is destroyed or 
suppressed by other solubilization methods. Substitution of leucine with phenylalanine to 
attain K2(QF)5K2 results in even better SWCNT fluorescence. However, multidomain 
peptides bearing lysine residues on the termini aggregate in the presence of cell culture 
medium, making them unsuitable for biological applications. The substitution of 
positively-charged lysine with negatively-charged glutamic acid results in two peptides 
that suspend SWCNTs and are compatible with cell culture. These peptides, E(QL)6E and 
E(QL)6EGRGDS, were examined to determine their toxicity. It was found that at low 
concentrations, peptide surfactants were nontoxic to cells, while at higher concentrations, 
some toxicity was observed. When these peptide surfactants were used to deliver 
SWCNTs to fibroblast cultures, no significant difference was found between cultures 
treated with peptide-SWCNT suspensions and those treated with peptide solutions alone. 
Thus, during this study, we were also able to determine that single-walled carbon 
nanotubes are nontoxic to fibroblasts. 
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These applications demonstrate that multi domain peptides make up a highly versatile 
platform that is customizable to accomplish different objectives. Whether we are seeking 
sustained drug release from a robust hydrogel or the next new surfactant, multi domain 
peptides can take advantage of the wide range of functional groups available to make this 
happen. Their strong tendency to reside in the j3-sheet conformation means that these 
modifications can be tolerated without sacrificing the novel self-assembled 
nanostructures formed by these peptides. This resilient system is yet another testament to 
the power of molecular self-assembly. 
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Appendix 1: Peptide Library (alphabetical order) 
Peptide Relevant Chapter(s) 
C4K2(QL)sK2 Chapter 5 
E(QL)6E Chapter 5 
E(QL)6EGRGDS Chapter 5 
E(SL)6E Chapter 2 
E2(QF)sE2 Chapter 5 
E2(QF)6E2 Chapter 5 
E2(QL)6E2 Chapter 5 
E2(SL )3RG(SL )3E2GRGDS Chapter 2 
E2(SL)6E2 Chapters 2, 3 
E2(SL )6E2GRGDS Chapters 2, 4 
K(SL )3RG(SL )3KGRGDS Chapter 2 
K2(CLQL)3K2 Chapter 2 
K2(QF)sK2 Chapter 5 
K2(QF)6K2 Chapters 2, 5 
K2(QFQL)3K2 Chapter 2 
K2(QL)sK2 Chapters 2, 5 
K2(QL)6K2 Chapters 2, 5 
K2(QW)sK2 Chapter 2 
K2(QW)6K2 Chapter 2 
K2(QY)sK2 Chapter 2 
K2(QY)6K2 Chapter 2 
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K2(SF)5K2 Chapter 2 
K2(SF)6K2 Chapter 2 
K2(SL)6K2 Chapters 2, 3 
K2(SL )6K2GRGDS Chapter 2 
K2(SW)5K2 Chapter 2 
K2(SW)6K2 Chapter 2 
K2(TL)6K2 Chapter 2 
K2C(QL)6CK2 Chapter 5 
K3(QF)6K3 Chapter 2 
K3(QL)6K3 Chapters 2, 5 
QK2(SL)6K2Q Chapter 2 
-------
Appendix 2: Mass Spectrometry of Peptides 
Mass spectra of pep tides were achieved using standard MALDI techniques on a 
Bruker Autoflex mass spectrometer as discussed in previous chapters. Spectra were 
processed using FlexAnalysis software. 
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